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CHAPTER I
INTRODUCTION
Cardiovascular disease (CVD) is a broad term referring to numerous conditions
characterized by dysfunction of the heart and blood vessels. One in four Americans, over
60 million persons, will experience some type of CVD during their lifetime. CVD is the
leading cause of death in the United States, accounting for approximately 910,000 deaths
per year. Many factors are linked to the development of CVD, including blood
cholesterol levels, hypertension, physical inactivity, diet and cigarette smoking (Center
for Disease Control and Prevention, 2006). These factors influence the development of
the two major forms of CVD, which are termed atherosclerosis and arteriosclerosis.
Atherosclerosis is an accumulation of plaque that causes narrowing for the blood vessel
and an eventual loss of blood vessel elasticity (Gylys & Wedding, 2005). Arteriosclerosis
is a hardening of the arterial walls that usually results from an accumulation of a plaquelike substance composed of cholesterol, lipids and cellular debris along the innermost
lining of the arterial walls (Gylys & Wedding, 2005).
Development of atherosclerosis and arteriosclerosis occurs over a long period of
time (Scott, 2004). Three common manifestations of CVD related to atherosclerosis and
1
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arteriosclerosis are heart attack or myocardial infarction, heart failure, and stroke (Scott,
2004). Ischemic heart disease, coronary heart disease (CHD), or coronary artery disease
(CAD) all refer to the same condition that results from accumulation of plaque within the
coronary blood vessels, and accounts for the approximately 35% of all deaths in United
States annually. Deaths may occur suddenly as a result of an acute coronary artery
occlusion (ischemic heart disease) or cardiac fibrillation (Scott, 2004).
Research shows that factors such as physical activity, diet, body mass index
(BMI), and inflammatory markers are linked to CVD. Many studies have demonstrated
that physical activity has a great impact on health and mortality. Results from many
studies, including the Harvard Alumni Health Study (Lee, Hsieh, & Paffenbarger , 1995),
British Civil Service Study (Morris et al., 1980), Multiple Risk Factor Intervention Trial
(Leon et al., 1997) and Caerphilly Study (Yu, Yarnell, Sweetman, & Murray, 2003),
demonstrated that physical activity reduces risk of all-cause mortality, CVD, and
mortality related to CVD. More recently, studies have focused on the intensity as well as
the amount of physical activity required to obtain a reduction in CVD risk (Yu et al.,
2003). Aerobic exercise of high intensity clearly has been demonstrated to reduce CVD
incidence and CVD-related mortality (Yu et al., 2003). Some, but not all, studies show
that participation in exercise of moderate intensity also decreases the occurrence of CVD
and CVD-related mortality (Barengo, Hu, Lakka, Pakkarinen, Nissinen, & Tuomilehto,
2004; Leon, Myers, & Connett, 1997). The United States Dietary Association’s Dietary
Guidelines recommend participation in physical activity at a level that matches the
number of calories expended with calories consumed, and walking or doing other
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physical activity of a minimum of 30 minutes per day on most days of the week
(American Heart Association, 2006). Current American College of Sports Medicine
guidelines recommend that individuals participate in a minimum of 30 minutes or more
of moderate intensity physical activity on three or more days per week in order to acquire
the beneficial effects of exercise (Anderson, Blair, Cheskin, & Bartlett, 1997); (American
College of Sports Medicine, 1998).
Participation in physical activity programs typically increases cardiorespiratory
fitness, which is often assessed using maximal oxygen consumption (VO2max).
Individuals with higher levels of cardiorespiratory fitness have reduced risks of
progression of CAD and death due to CVD compared with individuals with low fitness
(Lakka, Laukkanen, Rauramaa, Salonen, Lakka, Kaplan et al., 2001; Laukkanen, Lakka,
Rauramaa, Kuhanen, Venalainene, Salonen, et al., 2001).
Although physical activity plays a significant role in reducing CVD risk, BMI
also contributes to the risk for CVD. BMI is a measure of an individual’s body weight
relative to height, and is expressed as kilograms of body weight per height in square
meters. In general, a greater BMI is associated with an increase in body fatness. In the
United States, over 60% of individuals are overweight based on BMI (BMI > 25 kg/m2),
and approximately 25% of the population is obese (BMI > 30 kg/m2) (Center for Disease
Control and Prevention, 2003). The Framingham Heart Study demonstrated that risk for
CVD was increased in overweight and obese men and women compared to men and
women of normal weight (Wilson, Garrison, Castelli, Feinleib, McNamara, Kannel et al.,
1980). In the Caerphilly Prospective Study, men with BMI values of 30 kg/m2 or greater
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were at increased risk for CHD and overall mortality (Yarnell, Patternson, Hugh, &
Sweetman, 2000). In the Whitehall study of London-based male government employees
there was an elevated risk of mortality related to CHD in overweight and obese men
(Batty, Shipley, Jarrett, Breeze, Marmot & Davey Smith., 2005).
Many studies have established a link between serum cholesterol and CVD. Serum
cholesterol is a strong predictor of CHD and all-cause mortality in middle-aged
populations (Anderson, Castelli, & Levy, 1987; Benfante & Reed, 1990; Martin, Hulley,
Browner, Kuller, & Wentworth., 1986). Increased levels of low-density lipoproteincholesterol (LDL-C) have been associated with the progression of CVD (Huxley,
Lewington, & Clarke, 2002; Nicholls & Lundman, 2004), while greater levels of HDL
are inversely related to CVD. It is very important to note that conventional markers for
CVD risk do not accurately predict the likelihood of CVD in many individuals (Blake &
Ridker, 2002). Inflammatory markers, especially C-reactive protein (CRP) and
homocysteine, may have stronger relationships than cholesterol levels with progression
of coronary artery disease (Rasouli, Nasir, Blumenthal, Park, Aziz, & Budoff, 2005).
Overweight and obesity may affect the heart and cardiovascular system through
its influence on many risk factors, such as dyslipidemia, glucose intolerance,
inflammatory markers, hypertension and promotion of a prothrombotic state (Poirier &
Despres., 2006). Overweight and obesity predispose to or are associated with numerous
cardiac complications such as coronary heart disease, heart failure, and sudden death
because of their impact on the cardiovascular system. Higher blood glucose levels are a
marker for impaired glucose tolerance or increased resistance to insulin. Elevated blood

5
glucose has been linked to an increased risk of CVD (Bowman & Armitage, 2002:
Petersen & McGuire, 2005; Schnell, 2005). Furthermore, elevated serum glucose levels
have been linked with low grade inflammation (Barzilay & Freedland, 2003). Reduction
in body weight, especially body fatness, and participation in physical activity may
improve blood glucose levels, thus decreasing the likelihood of CVD.
Inflammatory mechanisms play a prominent role in mediating all stages of
atherosclerosis, and measurement of inflammatory biomarkers, such as CRP, may be
useful for detecting individuals at risk for CVD. CRP is present at very low levels in the
blood and is an extremely sensitive marker of inflammation. CRP may originate from
various tissues, which apparently includes plaque formed through the atherosclerotic
process (Blake & Ridker, 2002). Evidence from observational studies indicates that CRP
is the strongest predictor of future myocardial infarction and stroke (Koenig, 2005;
LaMonte, Durstine, Yanowitz, Lim, DuBose, Davis, et al 2002). In fact, CRP has been
shown to accurately predict risk of cardiovascular events even in individuals with low
levels of LDL-C (Nambi & Balantyne, 2005). The addition of CRP to standard lipid
screening may improve global risk prediction among those with high as well as low
cholesterol levels.
Results of studies examining the effect of regular physical activity on CRP levels
are somewhat equivocal. Cross-sectional studies suggest that physical activity reduces
CRP levels (Colbert, Visser, Simonsick, Tracy, Newman, Kritchevsky et al., 2004;
Reuben, Judd-Hamilton, Harris, & Seemanet, 2003), but results from longitudinal studies
are inconsistent (Lakka, Lakka, Rankinen, Leon, Rao, Skinner.et al., 2005; Nicklas et al.,
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2004; Rauramaa, Halonen, Vaisanen, Lakka, Schmidt-Trucksass, Berg et al., 2004). BMI
and body fatness appear to be more closely associated with CRP levels than physical
activity (Tamakoshi, Yatsuya, Kondo, Ishikawa, Zhang, Murata et al., 2003; Thorand,
Baumert, Doring, Herder, Kolb, Rathmann, et al., 2006), and reductions in body weight
and fatness result in declines in CRP (Tchernof, Nolan, & Sites, 2002).
Homocysteine is another prominent inflammatory marker that has been shown to
be related significantly to CVD risk (Aronow & Ahn, 2000; Kario, Duell, Matsuo,
Sakata, Kato, Shimada et al., 2001; Lindeman, Romero, Yau, Koehler, Baumgartner, &
Garry, 2003; Nurk, Tell, Vollset, Nygard, Refsum, & Ueland, 2002). Homocysteine can
induce damage of the tunica intima of the arterial wall and trigger atherosclerosis. Most,
but not all, observational epidemiological studies indicate that individuals with higher
homocysteine levels have increased risks of CVD. The magnitude ranges from
approximately 20% in prospective studies to approximately 80% in retrospective casecontrol studies (Splaver, Lamas, & Hennekens, 2004). Homocysteine levels are related to
physical activity, BMI, diet and other lifestyle factors. Individuals who are physically
active are more likely to have lower homocysteine levels (Dankner, Chetrit, Lubin, &
Sela, 2004; Panagiotakos, Pitsavos, Zeimbekis, Chryysohoou, & Stefanadis, 2005).
Homocysteine levels were positively related with BMI in young and older women
(Rasmussen Ovesen, Bulow, Knudsen, Laurberg, & Perrild, 2000), as well as in obese
children and adolescents (Gallistl, Sudi, Erwa, Aigner, & Borkenstein, 2001).
Homocysteine has been shown to be inversely related to dietary folate (Coombes, Fraser,
Sharman, & Booth, 2004) and serum folate (Lindemann et al., 2003). Physical activity
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and a reduction in body fatness may improve homocysteine levels, thus decreasing the
risk of CVD (Colbert et al., 2004).
Physical activity increases physical fitness and plays a major role in the reduction
of many diseases including CVD. Physical activity also may assist with maintenance of a
healthy body weight. Blood lipid levels as well as the inflammatory markers, CRP and
homocysteine, are related to CVD incidence. Exercise decreases the occurrence of CVD
if performed on a consistent basis, but there is a lack of research on the effect of physical
activity on CRP and homocysteine (Anderson et al, 1997). The purpose of this study was
to determine the relationship between BMI and physical fitness, blood lipids, and
inflammatory markers, as well as the relationship of these variables to cardiovascular
disease using data from the National Health and Nutrition Examination Survey
(NHANES) 1999 - 2002. It was hypothesized that 1) individuals who were normal weight
based on BMI classification would have higher levels of physical fitness compared to
overweight and obese individuals; 2) individuals who were normal weight would have
lower serum triglyceride and total cholesterol levels compared with overweight and obese
individuals; 3) individuals who were normal weight would have lower serum glucose
levels compared with overweight and obese individuals; 4) individuals who were normal
weight would have lower serum levels of the inflammatory markers, CRP and
homocysteine, for CVD compared with overweight and obese individuals; and, 5)
individuals who were normal weight would have a greater age when they were told that
they had CHD compared with overweight and obese individuals.

CHAPTER II
LITERATURE REVIEW

Introduction
Cardiovascular disease (CVD) is a broad term referring to numerous abnormal
conditions that are characterized by dysfunction of the myocardium and blood vessels.
CVD includes arteriosclerosis and atherosclerosis and is the leading cause of death in the
United States, accounting for approximately 910,000 deaths per year (Center for Disease
Control and Prevention, 2006). Arteriosclerosis is a hardening of the arterial walls that
usually results from an accumulation of a plaque like substance composed of cholesterol,
lipids and cellular debris. This plaque accumulates on the tunica intima or innermost
lining of the arterial walls. Atherosclerosis is primarily a disease of the large arteries in
which lipid deposits referred to as atheromatous plaques appear on the inside layers of the
arteries (Gylys & Wedding, 2005). These plaques contain large amounts of cholesterol
and are associated with degeneration of the arterial walls. In later stages of the disease,
fibroblasts infiltrate the degenerative areas and cause progressive sclerosis of the arteries.
The plaques often extend through the intima of the blood vessel wall, protruding into the
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blood vessels and blocking blood flow. Additionally, calcium often precipitates with the
lipids to develop calcified plaques, resulting in a loss of elasticity or “hardening” of the
arteries. The loss of elasticity causes the atherosclerotic arteries to rupture more readily.
Finally, the roughened internal surface of the arteries can induce localized hemorrhage of
blood into the plaque that forms a clot or thrombus. A thrombus can cause an acute
obstruction of blood flow through the arteries resulting in partial or complete disruption
of blood flow to the myocardium or other tissues. Also, thrombi can dislodge and move
through the circulation as emboli. An embolus, which is defined as a mass of undissolved
matter circulating in the blood, can lodge in a blood vessel causing a localized infarct
(Gylys & Wedding, 2005).
Ischemic heart disease, coronary heart disease (CHD), or coronary artery disease
(CAD) all refer to the same condition and result from accumulation of plaque within the
coronary blood vessels. Approximately 20% of the total cardiac output is necessary to
meet the oxygen demands of the cardiac muscle. When blood flows through the coronary
arteries to localized areas of the myocardium is decreased, ischemia or lack of adequate
oxygenation occurs that can cause pain or angina pectoris. A complete lack of oxygen
results in a myocardial infarction and necrosis of the affected tissue. CHD accounts for
approximately 35% of all deaths in the United States.
There are numerous risk factors for CVD, some of which are genetically
determined and cannot be modified while other risk factors are modifiable. Risk factors
that can be modified include physical activity level, diet, and smoking. Increasing
physical activity is associated with a reduction in the risk for CHD; however, more than
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60% of adults in the United States are not physically active on a regular basis and 25% do
not participate in any physical activity (US Department of Health and Human Services).
Studies have demonstrated that higher levels of regular physical activity (Anderson, et al.
1997, Leon et al., 1987) and cardiorespiratory fitness (Lakka, Venalainen, Rauramaa,
Salonen, Tuomilehto, & Salonen, 1994) are associated with a reduced risk of CVD.

The Relationship of Physical Activity and Physical Fitness with Mortality and
Cardiovascular Disease
It is widely accepted that regular physical activity is associated with a reduced
risk of many chronic diseases, including CVD. Classic epidemiological studies have
established that increasing levels of physical activity are inversely associated with the
risk of CVD (Leon, Myers, & Connett, 1997; Morris, Everit, Pollard, Chave, &
Semmence, 1980; Paffenbarger, Hyde, Wing, Lee, Jung, Kampert, 1993; Rosengren &
Wilhelmsen, 1997). More recent studies have focused on the quantity and intensity of
physical activity necessary to reduce the risk for CVD. While the benefits of physical
activity of high or vigorous intensity are clear (Yu et al., 2003), the benefits of light and
moderate intensity exercise are equivocal (Barengo et al., 2004; Yu et al., 2003).
Results of the Harvard Alumni Health Study showed an inverse relationship
between physical activity and all-cause mortality and CVD mortality in men (Lee et al.,
1995). In the Harvard Alumni Health Study, 12,516 middle-aged and older men (mean
age of 57.7 years) were followed from 1977 through 1993. Sports or recreational
activities were reported by 74.1% of the men. Compared with men expending fewer than
2,100 kilojoules (kJ) per week, men expending 4,200 to 8,400 kJ per week had a 20%
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reduction in risk for CHD (Sesso, Paffenbarger, & Lee, 2000). Expending over 8,400 kJ
per week did not result in further reduction in CHD risk. Among men with multiple
coronary risk factors, those expending greater than 4,200 kJ per week had reduced CHD
risk compared with men expending less than 4,200 kJ per week. Most of the energy was
expended during moderate (4 to < 6 multiples of the resting metabolic equivalent
(METs)) and vigorous (> 6 METs) activities. Only total sports or recreational activities
and vigorous activities were associated with a decreased risk of CHD; light and moderate
activities were not associated with a reduction in risk for CHD. The authors expressed
concern that activities of light and moderate intensity may not have been measured
precisely (Sesso et al., 2000).
In another part of the Framingham study, the relationships of lifestyle changes to
all-cause mortality and death from CHD were examined in men who were 45 to 84 years
of age in 1977 and who had reported no life-threatening disease on questionnaires
completed in 1962 or 1966 and again in 1977 (Paffenbarger et al., 1993). Men were
classified according to lifestyle changes between completion of the first and second
questionnaires. Men who initiated participation in sports of moderately vigorous
intensity, defined as great than 4½ METs, had a 23% lower risk of death from CHD
compared with men who did not take up moderately vigorous exercise (Paffenbarger et
al. 1993).
The relationship between physical activity and the incidence of CHD was studied
in 17,944 middle-aged male British Civil Service office workers (Morris et al., 1980).
Men who reported engaging in vigorous sports during an initial survey in 1968-70 had an
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incidence of CHD over the following 8½ years that was approximately half that of their
colleagues who reported no vigorous exercise (Morris et al., 1980). Fatal and non-fatal
clinical events related to CHD were lower for men reporting participation in vigorous
exercise. This benefit of vigorous exercise was notable in individuals across all ageranges studied, but was more striking in individuals of later-middle age and early-old age.
Vigorous exercise also reduced non-fatal and fatal clinical events in all of the other subgroups examined, including men with a family history of CHD, men with severe
hypertension and sub-clinical angina, obese men and cigarette smokers (Morris et al.,
1980).
Data from the Multiple Risk Factor Intervention Trial (MRFIT), a prospective
study of 12,138 middle-aged men at high risk for CHD, showed that a relatively small
amount of daily moderate intensity leisure time physical activity (LTPA) can reduce
CHD-related mortality (Leon et al., 1997). Men were classified into deciles based on
average minutes per day (min/d) of LTPA reported at baseline, which was compared with
cumulative CHD and all-cause mortality after 16-years of follow-up. Men in the leastactive decile for LTPA, who averaged 4.9 min/d of LTPA, had excess age-adjusted
mortality rates of 29% and 22% for CHD and all-causes, respectively, as compared to
those in combined deciles 2 to 4, who averaged 22.7 min/d of predominantly light and
moderate LTPA. No further decrement in mortality rates was noted in those in the higher
deciles of LTPA. The MRFIT demonstrates that a modest amount (10 to 36 min/d) of
moderate intensity LTPA can significantly reduce premature mortality, particularly from
CHD, in middle-aged and older men at high risk for CHD (Leon et al., 1997). Data from
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MRFIT published after seven years of follow-up showed that moderate LTPA was
associated with 63% fewer fatal CHD events and sudden deaths and 70% fewer total
deaths compared with low LTPA (Leon et al., 1987). Combined fatal and nonfatal major
CHD events were 20% lower with high LTPA as compared with low LTPA. It was
concluded that LTPA has a modest inverse relation to CHD and overall mortality in
middle-aged men at high risk for CHD (Leon et al., 1987).
The relationship between LTPA and CHD disease mortality and all-cause
mortality was examined in white male US railroad workers during 17 to 20 years of
follow-up (Slattery, Jacobs, & Nichaman, 1989). The cohort, which was initially
examined from 1957 to 1960 and reexamined from 1962 to 1964, was followed until
either 1977 or death. The risk estimate for death from CHD, after adjusting for age, was
1.39 for sedentary men who expended 40 kilocalories (kcal) per week in LTPA compared
with very active men who expended 3,632 kcal per week. Although the risk estimate was
mitigated when adjusted for other CHD risk factors it remained statistically significant.
Caloric expenditure from light and moderate activity, as well as that performed during
intense activity, showed independent relationships to cardiovascular death and all-cause
mortality. The US railroad workers’ study demonstrated that physical activity reduces allcause mortality and mortality due to CHD (Slattery et al., 1989).
The relationship of moderate or high LTPA or occupational physical activity and
commuting activity with all-cause mortality and CVD-related mortality were studied as
part of a prospective follow-up (median follow-up time 20 years) of 15,853 men and
16,824 women, aged 30 to 59 years, living in eastern and south-western Finland (Barengo
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et al., 2004). CVD and all-cause mortality were reduced 9 to 21% in men and 2 to 17% in
women who were moderately or highly physically active during leisure time. Moderate
and high levels of occupational physical activity also reduced CVD-related and all-cause
mortality by 21 to 27% in men and women. Women who spent at least 15 minutes per
day walking or cycling to and from work had a reduced CVD-related and all-cause
mortality prior to adjusting for occupational and LTPA. Commuting activity was not
associated with CVD-related or all-cause mortality in men. Moderate and high levels of
LTPA and occupational physical activity are associated with a reduced CVD and allcause mortality in both men and women (Barengo et al., 2004).
In an observational study of 9,824 U.S. adults, aged 51 to 61 years in 1992,
individuals who performed regular moderate to vigorous physical activity had a
substantially lower overall mortality, odds ratio = 0.62, compared with sedentary
individuals (Richardson, Kriska, Lantz, & Hayward, 2004). Participants performing
regular moderate to vigorous exercisers had an odds ratio of 0.55 for CVD related
mortality compared to sedentary individuals. Even persons performing occasional or light
exercises had an odds ratio of 0.55 compared with sedentary individuals. Individuals with
the greatest CVD risk had the most significant benefit from being physically active
(Richardson et al., 2004).
In a 16-year follow-up study of middle-aged men and women in Finland, an
increase in self-reported LTPA appeared to have similar beneficial effect on the mortality
risk of obese and nonobese men and women, as well as for fit and unfit subjects
(Haapanen-Niemi, Miilunpalo, Pasanen, Vuori, Oja, et al., 2000). There was a very
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strong relationship between LTPA and CVD in women with a relative risk of 4.68 for
women reporting no vigorous physical activity compared with the most active women. In
men, the relationship was weaker, with a relative risk for CVD of 1.61 for men reporting
no LTPA compared with the most active men (Haapanen-Niemi et al., 2000).
The Whitehall study was a prospective cohort study of London civil servants that
followed 6,702 men, aged 40 to 64 years at entry into the study, for up to 25 years
(Davey Smith, Shipley, Batty, Morris, & Marmot, 2000). LTPA was inversely associated
with mortality from all-causes, CHD, and other types of CVD following adjustment for
other risk factors. Walking pace was inversely associated with all-cause mortality, as well
as mortality from CHD and other CVD (Davey Smith et al., 2000).
Although there is debate about the importance of physical activity compared with
physical fitness in relation to risk for CVD, participation in physical activity programs
typically increases cardiorespiratory fitness. The most important measurement of
cardiorespiratory fitness is maximal oxygen consumption (VO2max). The Kuopio
Ischemic Heart Disease Risk Factor Study, a population-based cohort study of 1,294
healthy men in Kuopio and surrounding communities in eastern Finland, examined the
relationship of cardiorespiratory fitness at the initiation of the study with overall- and
CVD-related mortality (Laukkanen et al., 2001). Maximal oxygen consumption and
exercise duration during a fitness test were measured in order to assess cardiorespiratory
fitness. The men were followed for an average time of 10.7 years. There was a higher
mortality rate in unfit men compared to fit men. The relative risk of death due to all
causes was 2.76 unfit men (VO2max < 27.6 milliliters per kilogram per minute (ml/kg
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per minute)) compared to fit men (VO2max > 37.1 ml/kg per minute) after adjusting for
age, examination years, smoking, and alcohol consumption. The relative risk for death
due to CVD was 3.09 in unfit compared to fit men. Additional adjustments for various
factors including serum lipid levels, blood pressure, plasma fibrinogen level, diabetes,
and fasting serum insulin level did not alter these associations significantly. Also,
duration of the exercise test had a strong inverse relationship with overall and CVDrelated mortality. It was concluded that both maximal oxygen uptake and the duration of
the exercise test were strong predictors of all-cause mortality as well as CVD-related
mortality (Laukkanen et al., 2001).
Over an average follow-up of 4.9 years in 1,453 men, 42 to 60 years of age upon
entry into the study, the relative risk of myocardial infarction in the upper third of
subjects with the highest level of physical activity (> 2.2 hours physical activity per
week) was 0.31 as compared with subjects in the lower third for physical activity level
(Lakka et al., 1994). The relative risk of myocardial infarction for study participants in
the upper third for maximal oxygen uptake (> 2.7 liters per minute) was 0.26 after
adjustment for age and other factors. Even after adjustment for up to 17 confounding
variables, there was little change in relative risk for subjects in the highest third for
physical activity or maximal oxygen uptake as compared with the participants in the
lowest third. Higher levels of both LTPA and cardiorespiratory fitness had strong,
graded, inverse relationships with the risk of acute myocardial infarction, supporting the
hypothesis that lower levels of physical activity and cardiorespiratory fitness are
independent risk factors for CHD (Lakka et al., 1994).

17
The relationship between cardiorespiratory fitness and the progression of early
carotid atherosclerosis was examined during a 4-year follow-up study in men, 42 to 60
years of age. VO2max, which is a measure of cardiorespiratory fitness, had strong,
inverse, and graded associations with 4-year increases in progression of carotid
atherosclerosis (Lakka et al., 2001). Good cardiorespiratory fitness was shown to be
associated with slower progression of early atherosclerosis in middle-aged men (Lakka et
al., 2001).

The Relationship of the Duration and Intensity of Physical Activity with Mortality and
Cardiovascular Disease
It is unclear whether the total amount of physical activity, often expressed as total
energy expended, or the intensity of physical activity, which is represented as the rate of
energy expenditure, is more important in reducing CVD or CHD risk. Some studies
demonstrate that regular, vigorous physical activity is necessary for a decreased risk of
CVD and CHD-related mortality (Morris et al., 1980; Laaka et al. 1994). Other studies
show that the total amount of energy expenditure, including that of moderate intensity, is
sufficient to decrease the CVD and CHD-related mortality (Leon et al., 1987;
Paffenbarger et al., 1993; Slattery et al., 1989). The United States railroad workers study
showed that both moderate and vigorous activity could contribute to the reduction in
CVD-related death (Slattery et al., 1989).
Data from the Framingham Heart Study demonstrated that the duration of
physical activity played a key role in extending life expectancy and the number of years
lived without CVD (Franco, Peeters, Bonneux, & De Laet, 2005). Data were used to
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calculate the consequences of three different physical activity levels (low, moderate, and
high) after age 50 years on total life expectancy and life expectancy with and without
CVD. Hazard ratios for three transitions (healthy to death, healthy to disease, and disease
to death) were calculated by levels of physical activity and adjusted for age, sex, smoking
status and co-morbidities. In men, moderate and high levels of physical activity levels
were associated with a calculated increase in life expectancy of 1.3 and 3.7 years,
respectively. Also, moderate and high levels of physical activity levels increased the
amount of time lived without CVD by 1.1 and 3.2 years, respectively compared with
those who maintained a low physical activity level. For women, moderate and high levels
of physical activity levels increased life expectancy 1.5 and 3.5 years, respectively, and
also increased the amount of time lived free of CVD by 1.3 and 3.3, respectively.
Engaging in moderate or high levels of physical activity not only increases life
expectancy, but also extends the CVD-free life expectancy in both men and women
(Franco et al., 2005).
The relationship between the duration and intensity of LTPA and the risk of CHD
was examined in healthy middle-aged men and women, aged 35 to 63 years, in
northeastern Finland during 10 years of follow-up (Haapanen, Miilunpalo, Pasanen, Oja,
& Vuori, 1997). Subjects were divided into groups based on the amount of LTPA (three
levels) and the intensity of LTPA (two levels). An increase in the total amount of LTPA
was associated with a reduced CHD risk in men but not among women. After adjustment
for smoking status, the risk of CHD in men was twice as great in the low duration LTPA
group compared with the high duration LTPA group (Haapanen et al, 1997). The
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intensity of LTPA was not statistically associated with the risk of CHD for either men or
women (Haapanen et al., 1997).
A cohort of 44,452 men, who were enrolled in the Health Professionals' Followup Study, were followed at 2-year intervals for 12 years (Tanasescu, Leitzmann, Rimm,
Willett, Stampfer, & Hu, 2003). Total physical activity, running, weight training, and
rowing were each inversely associated with risk of CHD. Men in the two highest
quintiles of total physical activity had a reduced relative risk for incident nonfatal
myocardial infarction or fatal CHD occurring during the follow-up period compared to
men in the lowest physical activity quintile. Men who ran for an hour or more per week
had a 42% risk reduction compared with men who did not run. Men who performed
resistance training for 30 minutes or more per week had a 23% risk reduction compared
with men who did not train with weights. Rowing for one hour or more per week was
associated with an 18% risk reduction. Average exercise intensity was associated with
reduced CHD risk independent of the total volume of physical activity. Participants
engaging in physical activity corresponding to high intensities (6 to 12 METs) had a
decreased relative risk for incident nonfatal myocardial infarction or fatal CHD compared
with individuals who performed on low intensity activity (< 4 METs) (Tanasescu et al.,
2003). Individuals participating in moderate intensity activity (4 to 6 METs) did not have
a significant reduction in risk. One-half hour per day or more of brisk walking was
associated with an 18% risk reduction. and walking pace was associated with reduced
CHD risk independent of the number of walking hours. Total physical activity, running,
weight training, and walking were each associated with reduced CHD risk. Average
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exercise intensity was associated with reduced risk independent of the number of METhours spent in physical activity (Tanasescu et al., 2003).
The Caerphilly study examined the optimal intensity of LTPA that was associated
with a decreased risk of all-cause mortality, as well as mortality due to CVD and CHD, in
middle-aged British men during 11 years of follow-up (Yu et al., 2003). Cumulative
LTPA had a significant and graded relationship with all-cause, CVD and CHD mortality.
When different intensities of activity were considered, light and moderate intensity LTPA
had inconsistent and non-significant relations with all-cause, CVD, or CHD mortality
whether adjusted only for age or adjusted for other cardiovascular risk factors as well. In
contrast, there was a significant dose-response relationship between heavy intensity
LTPA for all-cause, CVD, and CHD mortality even after adjustment for other risk
factors. In a population of men without evidence of CHD at baseline, only LTPA
classified as heavy or vigorous was independently associated with a reduction in all-cause
mortality and reduced risks of premature death from CVD including CHD (Yu et al.,
2003).
Reasons for discrepancies between studies with regard to the significance of the
duration and intensity of exercise include the definition of vigorous exercise used in
various studies and the number of times per week and length of study. In shorter-term
studies, only higher intensities of physical activity may be related to reduction in allcause and CVD-related mortality. In longer term studies, the relationship of moderate
exercise intensity may become more apparent.
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Physical activity may Modify Risk for Cardiovascular Disease and Morbidity through
its Effect on other Risk Factors.
The beneficial effects of LTPA in reducing all-cause mortality and CVD-related
mortality may be mediated through its effect on various risk factors. Physical activity has
been associated with reduction in the incidence of several risk factors including diabetes,
hypertension, smoking status and BMI. Higher BMI values and diabetes were associated
with increased CHD risk after controlling for age and LTPA energy expenditure
(Haapanen et al, 1997). The relationship between physical activity and CHD was
examined over a 23-year period in men of Japanese heritage in the Honolulu Heart
Program (Rodriguez, Curb, Burchfield, Abbott, Petrovitch, Masaki, et al., 1994). The
Framingham physical activity index was used to assess physical activity level duration
and intensity. Individuals in the highest tertile for physical activity had a significant
reduction in risk for CHD and death from CHD compared to men in the lowest physical
activity group. However, when relative risk was adjusted for age, hypertension, smoking,
alcohol intake, diabetes, cholesterol, and BMI, the relationship between physical activity
and CHD mortality was no longer significant suggesting that the beneficial effects of
physical activity were due to the effects of physical activity in reducing hypertension,
diabetes, cholesterol levels and BMI (Rodriguez et al., 1994).

The Relationship between BMI and Cardiovascular Disease
Body weight, body fatness and the pattern of fat deposition appear to be related to
the risk for CVD. Body mass index (BMI) is a measure of an individual’s body weight
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relative to height. It is calculated as the quotient of body weight in kilograms divided by
height expressed as square meters. Values of 25 kilograms per square meters of height
(kg/m2) or greater are considered overweight and values greater than 30 kg/m2 are
considered obese (Cheung, Machin, Karlberg, & Khoo, 2004). BMI is a widely used
screening tool for assessing an individual’s risk for disease and as BMI increases above
25 kg/m2 there is an exponential increase in mortality rate and risk of CVD.
BMI data from the third National Health and Nutrition Examination Survey
(NHANES III) showed that approximately 63% of men and 55% of women in the United
States were overweight or obese (Must, Spadano, Coakley, Field, Colditz, & Dietz,
1999). Overweight and obese men have an excess risk of CHD as well as overall
mortality (Yarnell, Patterson, Thomas, & Sweetman., 2000). Lack of physical activity, as
well as overweight and obesity, are related to an increased incidence of CVD (Anderson.
et al., 1997 & Takami, Takeda, Hayashim, Sasaki, Kawachi, Yoshino, et al, 2001).
Regular physical activity may prevent body mass gain, which is primarily due to an
increase in body fat, in adults. Physical inactivity is a risk factor for body mass gain and
obesity among adults (Haapanen et al., 1997). A decrease in body fat as a result of
physical activity also attenuates the development of CVD (Colbert, et al., 2004).
The Framingham Heart Study, which followed individuals who were 35 to 75
years of age over a 44-year period, demonstrated that CVD-risk was increased in
overweight and obese men and women compared to men and women of normal weight
(Wilson, D’Agostina, Sullivan, Parise, & Kanne., 2002). In the Caerphilly Prospective
Study, men aged 45 to 59 years were followed over a 14-year period in order to examine
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the influence of weight change on mortality and coronary events. Study participants were
asked their weight at 18 years of age. This weight was compared to their current body
weight and their body weight after 14 years of follow-up. Men with BMI values of 30
kg/m2 or greater were shown to be at a greater risk for CHD and overall mortality
(Yarnell et al., 2000).
In the Whitehall study of London-based male government employees with and
without prevalent CHD, 18,403 middle-age men were followed for up to 35 years (Batty
et al., 2005). In men with CHD as well as healthy men at entry into the study, overweight
men had a moderately greater risk for all-cause mortality and CHD mortality. Mortality
rates also were increased in the obese group. Avoidance of overweight and obesity in
adult life in both men with and without CHD may reduce the risk of total and CHD
mortality (Batty et al., 2005).
The risk of death from CHD and all causes associated with BMI and weight gain
from age 20 to middle age was assessed in 6,874 men, aged 47 to 55 years at baseline
(Rosengren et al., 1999). All men were free of a history of myocardial infarction and
were followed for non-fatal myocardial infarction for an average of 11.8 years.
Participants also were followed for CHD-related mortality and all-cause mortality over an
average period of 19.7 years. BMI greater than 27.5 m/kg2 predicted death from CHD.
Men with stable weight (defined as < ± 4% change from age 20) had the lowest risk of
non-fatal myocardial infarction and the lowest death rate. Men who increased body
weight more than 35% had a relative risk of 3.35 for non-fatal myocardial infarction after
adjustment for age, physical activity, and smoking compared with men of stable body
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weight. The relative risk of death from CHD was 1.57 (after adjustment for age, physical
activity, and smoking) in the group that gained 4 to 10% to 2.76 in the group that gained
more than 35% compared to men with stable weight. Relative risks were reduced but still
significantly elevated in all weight gain groups after adjustment for serum cholesterol,
systolic blood pressure, and diabetes. Weight gain from 20 years of age, even a very
moderate increase, is strongly associated with an increased risk of non-fatal myocardial
infarction and death related to CHD.
The relationship between being overweight or obese and mortality and morbidity
were examined in the Caerphilly Prospective Study (Yarnell et al., 2000). Males
reporting BMI values of 30 kg/m2 or greater at 18 years of age had an increased risk for
all-cause and CHD-related mortality during 14 years of follow-up when aged 45 to 59
years compared with non-obese men after adjustment for age, smoking habit and social
class. The effect of weight gain from 18 years of age to recruitment was examined also.
Weight gain during this period was strongly associated with potential cardiovascular risk
factors measured at recruitment, including insulin, triglyceride, glucose, diastolic and
systolic blood pressure and high-density lipoprotein-cholesterol (Yarnell et al., 2000).
Higher values of BMI were related to increased risk of new CHD when adjusted
for age, smoking habit and social class in the Caerphilly and Speedwell population
cohorts of men who were 45 to 59 years of age upon entry in the study (Yarnell,
Patterson, Sweetman, Thomas, Bainton, Elwood, et al., 2001). Also, individual skinfold
measurements (biceps, triceps, subscapular and abdominal skinfolds) and the sum of four
skinfolds were significantly associated with risk of new CHD when BMI was excluded
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from the regression model. However, only the subscapular skinfold measurement was
related independently to risk of subsequent CHD when BMI was included in the
regression model (Yarnell, Patterson, Thomas, & Sweetman., 2001). Individuals in the
upper quintile of subscapular skinfold thickness had almost a doubling in the likelihood
of CHD compared to individuals in the lowest quintile after adjustment (Yarnell et al.,
2001). This suggests that BMI and skinfold thickness are closely related, which might be
expected since BMI values would increase as body fatness increases. Although general
skinfold measurements contributed only marginally to improved prediction of risk of
CHD as measured by BMI, central obesity assessed by the subscapular skinfold
measurement was predictive of CHD independently of BMI (Yarnell et al., 2001).
Although the majority of studies show an increased risk of CVD with higher BMI
values, one important study is not consistent with this relationship. Self-reported BMI
was not an independent risk factor for mortality from CVD, CHD or from all causes
during 16 years of follow-up in men and women aged 35 to 63 years upon entry into the
study (Haapanen-Niemi et al., 2000).

Blood Lipids and Cardiovascular Disease
Many studies have established that serum cholesterol is a strong predictor of CVD
(Anderson et al., 1987; Benfante & Reed, 1990; Huxley et al., 2002; Martin et al., 1986).
Furthermore, elevated levels of low-density lipoprotein-cholesterol (LDL-C) and
triglycerides have been associated with the progression of CVD, while high-density
lipoprotein-cholesterol (HDL-C) levels are inversely associated with CVD (Huxley et al.,
2002; Nicholls et al., 2002). In the Framingham Offspring Study of men, aged 35 to 54
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years, total cholesterol, LDL-C and HDL-C has strong associations with the prevalence
of CHD (Wilson et al., 1980). The total cholesterol/HDL cholesterol ratio also had a
robust relationship with CHD. In the Framingham Study, HDL-C levels were inversely
related to development of CHD in both men and women aged 49 to 82 years, who were
followed up to 12 years (Castelli, Garrison, Wilson, Abbott, Kalousdian, & Kannel,
1986). Participants at the 80th percentile of HDL-C had one-half the risk of CHD
compared with subjects at the 20th percentile of HDL-C (Castelli et al., 1986).
In the Caerphilly and Speedwell population cohorts of men, 45 to 63 years of age,
fasting triglycerides, total cholesterol and HDL-C were strongly and independently
predictive of CHD after 10 years of follow-up (Yarnell et al., 2001). In a cohort of 8,006
men of Japanese ancestry, serum cholesterol and LDL-C levels measured during middle
age were predictive of incident CHD in elderly men 65 years of age and older (Reed &
Benfante, 1992). Although HDL-C had a protective effect against the incidence of CHD,
it was not a significant predictor of CHD in the elderly. Serum triglyceride level was not
a significant predictor of CHD for the elderly,
The risks associated with various levels of serum cholesterol were determined by
analysis of 6-year mortality in 361,662 men 35 to 57 years of age (Martin et al., 1986).
Above the 20th percentile for serum cholesterol (> 4.68 mmol/l), CHD mortality
increased progressively. The relative risk was very high (3.8) in men with cholesterol
levels above the 85th percentile (> 6.54 mmol/l). When men below the 20th percentile
were used as the baseline risk group, one-half of all CHD deaths were associated with
elevated serum cholesterol concentrations, and one-half of these excess deaths were in
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men with cholesterol levels above the 85th percentile (Martin et al., 1986). In the Primary
Prevention Study in Goteborg, Sweden, men, aged 51 to 59 years at entry into the study,
with serum cholesterol levels greater than 7.2 millimoles per liter (mmol/l) had a 2½-fold
greater risk of death related to CHD compared to men with cholesterol levels lower than
5.2 mmol/l during 16 years of follow-up (Rosengren et al., 1997).
For older individuals, several prospective population studies have reported
significant, positive correlations between the incidence of coronary events and serum
total cholesterol or LDL-C; however, in several studies the strength of the relationship
between cholesterol and CHD was weaker for older individuals (Kannel, Castelli, &
McNamara, 1971; Maniolo, Pearson, Wenger, Barrett-Connor, Payne, & Harlan, 1992) or
absent (Krumholz, Seeman, Merrill, Mendes de Leon, Vaccarino, 1994). In the
Framingham Heart Study, the risk ratio for CHD between participants in the highest and
lowest quartiles of total cholesterol were 3.6 for men younger than 50 years of age, but
2.2 for men greater than 50 years of age (Kannel et al., 1971). A later report from the
Framingham study followed total and CVD mortality over a 30-year period in a large
cohort of healthy men and women between 31 and 65 years of age (Anderson et al.,
1987). For participants under 50 years of age, cholesterol levels were directly related to
overall and CVD mortality; the CVD death rate increased 9% for each 10 mg/dL increase
in serum total cholesterol. In participants older than 50 years of age, total mortality was
not different in individuals with either high or low serum cholesterol levels; however, a
direct association between falling cholesterol levels over the first 14 years and mortality
over the following 18 years may have confounded the results. Overall mortality increased
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11% and the CVD death rate increased 14% per 1 mg/dL per year drop in cholesterol
levels. For individuals younger than 50 years of age, low total cholesterol levels were
associated with decreased total and CVD-related mortality, but after age 50 years of age
the association of mortality with cholesterol values likely was confounded by participants
whose cholesterol levels were falling, perhaps due to diseases predisposing these persons
to death (Anderson et al., 1987).
In the Honolulu Heart Program serum cholesterol levels were an important
predictor for CHD when measured after age 65 (Benfante, Reed, & Frank, 1992; Reed &
Benfante, 1992). The relationship between serum cholesterol and the 12-year incidence
of CHD was examined among 3,440 middle-aged men (51 to 59 years of age) and 1,419
elderly men (65 to 74 years of age) at baseline examination. Serum cholesterol level was
a significant predictor of CHD for both age groups. While the relative risk between serum
cholesterol and CHD was similar between middle-aged and elderly men, the excess risk
was typically between 1.5 to 2.0 times higher for the older than the middle-aged men
(Benfante et al., 1992).
In a cohort of elderly individuals, greater than 70 years of age, participating in the
Established Population for the Epidemiologic Study of the Elderly (EPESE) in New
Haven, Connecticut, elevated total serum cholesterol level, low HDL-C, and high total
serum cholesterol to HDL-C ratio were not associated with a significantly higher rate of
all-cause mortality, CHD mortality, or hospitalization for myocardial infarction or
unstable angina after adjustment for cardiovascular risk factors (Krumholz et al., 1994).
The relationship of CHD with total and LDL-C was examined during 129 months of
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follow-up in a cohort of men and women of 60 years of age and older (Simons, Simons,
Friedlander, & McCallum, 2001). Total cholesterol, LDL-C, and total cholesterol/HDL-C
were significant predictors of CHD only in the cohort of individuals who were 60 to 69
years of age, but not in cohorts who were 70 to 79 years of age or older than 80 years
(Simons et al., 2001). In a prospective, population-based study of adults, 65 years of age
and older, conducted at four field centers in U.S. communities with 7.5 years of followup, the relationships between total cholesterol and LDL-C and myocardial infarction were
only marginally significant; however, the association between low HDL-C and increased
risk of myocardial infarction was robust and consistent (Psaty, Anderson, Kronmal,
Tracy, Orchard, Fried, et al., 2004).
In a study that pooled risk estimates across 25 populations from 22 U.S. and
international cohort studies (Manolio et al., 1992), the relative risk of fatal CHD in
relationship to either total cholesterol or LDL-C was significant across a broad range of
ages up to 65 years of age. The relative risk of fatal CHD in relation to total cholesterol
and LDL-C, although still significant, was weakened with advancing age, especially in
women. HDL-C levels were inversely associated with CHD in middle-aged men and
women and in older women, but not in older men (Maniolo et al., 1992). Weakened
relationships between total cholesterol or LDL-C in elderly individuals may be due to the
effect of previous selection during the decades prior to study when individuals with
favorable genetics, i.e. those likely to survive despite elevated total or LDL cholesterol,
survived while individuals with less favorable genetics did not survive (Tikhonoff,
Casiglia, Mazza, Scarpa, Thijs, Pessiana, & Staessen, 2005).

30
Use of traditional cardiovascular risk factors, such as cholesterol, is imprecise and
predicts less than one half of future cardiovascular events (Rasouli et al., 2005). Overt
hyperlipidemia is present in fewer than half of all patients who have myocardial
infarctions (Blake & Ridker, 2001), suggesting that other factors must contribute to CVD.
Cholesterol levels were not a predictor of progression of coronary calcium, a measure of
coronary plaque burden, in older individuals (mean age 61 years) followed over eight to
80 months (Rasouli et al., 2005). CRP and homocysteine levels demonstrated a stronger
relationship than cholesterol levels with progression of CAD (Rasouli et al., 2005). CAD
has a significant inflammatory component (Libby & Theroux, 2005), and recent studies
have focused on whether plasma levels of inflammatory markers can assist in prediction
of individuals at increased risk of plaque rupture (Ridker, 1999).

Blood Lipids, Physical Activity, BMI and Heart Disease
Physical activity may reduce both body fatness and BMI as well as blood lipids.
Both of these effects may result in a reduced risk for CVD. Aerobic exercise was
effective for decreasing total cholesterol, LDL-C, and triglycerides and increasing HDLC in women (Kelley et al., 2004). Data from the Women's Ischemia Syndrome
Evaluation (WISE) study found that higher physical fitness scores using the self-reported
Duke Activity Standard Index (DASI) were independently associated with fewer CAD
risk factors, less angiographic CAD, and lower risk for adverse cardiovascular events in
women undergoing coronary angiography for suspected ischemia (Wessel, Arant, Olson,
Johnson, Reis, Sharaf, et al., 2004). Women who had lower DASI scores were more
likely to have more risk factors for CAD, although each 1-MET increase in DASI scores
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resulted in an 8% decline for risk of major adverse cardiovascular events during followup. Although overweight women were more likely than normal weight women to have
CAD risk factors, neither BMI nor abdominal obesity measures were significantly
associated with obstructive CAD or adverse cardiovascular events after adjusting for
other risk factors. Measures of obesity were not independently associated with these
outcomes (Wessel et al., 2004).
There is a close association between physical activity, overweight and obesity,
cholesterol levels and risk for CHD (Garrison, Wilson, Castelli, Feinleib, Kannel, &
McNamara, 1980). In Japanese-American men, aged 71 to 93 years, from the Honolulu
Heart Program, physical activity was positively associated with HDL cholesterol, while
BMI and subscapular skinfold thickness were negatively associated (Burchfiel, Abbott,
Sharp, Curb, Rodriguez, & Yano, 1996). Physical activity was associated with lower
triglyceride levels, while higher BMI and subscapular skinfold thickness was associated
with higher triglyceride levels. The relationship between physical activity or physical
fitness and decreased risk of all-cause and CVD-related mortality may be due in part to a
physical activity mediated reduction in total and LDL cholesterol, increase in HDL-C,
and reduction in body fatness and BMI.

Serum Glucose, BMI and Physical Activity
Obesity is associated with an increased risk of morbidity and mortality as well as
reduced life expectancy (Poirier & Despres, 2006). Overweight and obesity may affect
the heart and cardiovascular system through its influence on many risk factors, such as
dyslipidemia, glucose intolerance, inflammatory markers, hypertension and promotion of
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a prothrombotic state (Poirier & Despres, 2006). Higher blood glucose levels are an
indicator of impaired glucose tolerance or increased resistance to insulin. Elevated blood
glucose had been linked to an increased risk of CVD (Bowman & Armitage, 2002:
Petersen & McGuire, 2005; Schnell, 2005). For example, CVD is a major cause of the
reduction in life expectancy in patients with diabetes (Schnell, 2005). Seventy-five
percent of diabetic patients die prematurely of cardiovascular complications. Both
prediabetes and diabetes highly pre-dispose to cardiovascular alterations, and even serum
glucose levels at the upper end of the normal range may predispose individuals to an
increased risk of CVD (Schnell, 2005). Very importantly, elevated serum glucose levels
have been linked with low grade inflammation (Barzilay & Freedland, 2003). Decreasing
overweight and obesity, as well as participation in physical activity, may improve serum
glucose levels and reduce the risk of CVD.

Inflammation, C-Reactive Protein and Cardiovascular Disease
As discussed previously, it is now recognized that not only lipids, but
inflammation plays an important role in the development of atherosclerosis (Blake &
Ridker, 2001, 2002; Koenig et al., 2003). There is compelling evidence that local and
systemic inflammatory responses play key roles in the development of CVD (Danesh,
Whincup, Walker, Lennon, Thomson, Appleby et al., 2000; Koenig, Sund, Frohlich,
Fischer, Lowel, Doring, et al., 1999). Inflammatory processes may mediate many of the
stages of atheroma development from initial leukocyte recruitment to eventual rupture of
the unstable atherosclerotic plaque. Atherosclerosis, which underlies CHD, myocardial
infarction, ischemic stroke, and peripheral vascular disease, is linked in part to chronic,
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low-level inflammation of the vascular endothelium (Blake & Ridker, 2002, Danesh et
al., 2000; Ross, 1999, Scott, 2004)
Plasma levels of several markers of inflammation have been shown to be
associated with future CVD risk in a variety of clinical settings (Blake & Ridker, 2002).
These markers include CRP, homocysteine, cell adhesion molecules, cytokines, proatherogenic enzymes, serum amyloid-A, tumor necrosis factor-α (TNF- α), interleukin-6
(IL-6) and fibrinogen.

The Influence of C-Reactive Protein on Cardiovascular Disease
CRP is a member of a family of nonspecific, acute-phase reactant proteins (Gabay
& Kushner, 1999), and is a highly sensitive and objective marker of inflammation, tissue
damage and infection (Koenig et al., 2003). CRP is normally present in the circulation at
very low levels, but acute inflammatory processes, infections, or tissue injuries induce
marked increases in hepatic synthesis of CRP that can induce a 100-fold increase in
serum levels (Du Clos, 2000). Evidence also shows that arterial plaque can produce CRP,
independent of traditional hepatic pathways. Smooth muscle cells and macrophages
within the atherosclerotic plaque are sources of CRP (Vainas, Stassen, De Graaf, Twiss,
Herngreen, Weltem, et al., 2005; Yasojimz, Scwab, McGeer, & McGeer, 2001).
Additionally, coronary plaques, aneurysmal aortas, failed venous coronary bypasses, and
femoral plaques also produce CRP, thus illustrating that the production of CRP may
represent a universal response to vascular injury and suggesting that vascular CRP may
contribute to plaque development (Vainas et al., 2005).
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Initially thought of as an inactive downstream marker in the inflammatory
cascade, emerging evidence suggests that CRP may be directly involved in atherogenesis
(Blake & Ridker, 2001; Koenig et al., 2003). Furthermore, CRP has been demonstrated to
actively contribute to all stages of atherogenesis, participating in endothelial dysfunction,
atherosclerotic-plaque formation, plaque maturation, plaque destabilization and eventual
rupture (Verma, Szmitko, & Ridker., 2005). The presence of inflammation as
demonstrated on autopsy in patients with lethal myocardial infarctions through the
accumulation of monocytes and macrophages at the sites of plaque rupture, suggests that
inflammatory markers such as serum CRP levels may reflect the atherosclerotic process
and could potentially help identify those at risk of future events (Wilcox, Abbott, Yano,
Rodriguez, Willcox, Tanaka, et al., 2004).
Data supporting the role of CRP for cardiovascular risk prediction in apparently
healthy individuals are robust and remarkably consistent across several studies in Europe
and the United States (Ridker, Hennekens, Buring, & Rifai., 2000; Kuller, Tracy, Shaten,
& Meilahn, 1996; Koenig, Sund, Frohlich, Fischer, Lowel, Doring, et al., 1999; Tracy,
Lemaitre, Psaty, Ives, Evans, Cushman, et al., 1997; Ridker, Glynn, & Hennekens, et al.,
1998). Multiple prospective studies in the United States with middle-aged men (e.g., the
Honolulu Heart Program, (Curb, Abbott, Rodriguez, Sakkinen et al. 2003; Sakkinen,
Abbott, Curb, Rodriguez, Yano, & Tracy, 2002), Physicians' Health Study (Ridker,
Cushman, Stampfer, Tracy, & Hennekens., 1997; Ridker et al., 1998), and Multiple Risk
Factor Intervention Trial (MR FIT) (Kuller et al., 1996)), postmenopausal women (e.g.,
the Women's Health Study (Ridker et al., 2000, Ridker et al., 1998)), and elderly men and
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women (e.g., the Cardiovascular Health Study and Rural Health Promotion Project
(Tracy et al., 1997)) have shown that CRP is a strong, robust, and independent risk factor
for CVD. Additional studies of middle-aged men in the United Kingdom (Mendall et al.,
1996), Germany (MONICA Study, Koenig et al., 1999), and Finland (Roivainen, VViikKajander, Palosuo, Toivanen, Leinonen, Saikku, et al., 2000) support the US findings.
Baseline levels of CRP are a strong and independent predictor for risk of myocardial
infarction, stroke, peripheral vascular disease, as well as death from stroke and vascular
disease among healthy individuals (Blake & Ridker, 2002; Vainas et al., 2005). Serum
CRP has been shown to be an independent marker of the extent of atherosclerosis in
patients with coronary, cerebrovascular, and peripheral arterial disease. CRP is an
independent determinant of stroke (Curb et al. 2003), which is a form of CVD, among
both men and women.
The association between CRP and CHD were examined in a large combined
analysis from the Caerphilly and Speedwell population cohorts (Lowe, Sweetman,
Yarnell, Rumley, Rumley,Bainton, et al., 2004). Men, aged 49 to 66 years, were studied
between 1982 and 1988 and re-examined for new CHD events at fixed intervals of
approximately 105 months (Caerphilly study) and 75 months (Speedwell study) (Lowe et
al., 2004). Mean levels of CRP were significantly higher among men who developed
CHD. Men in the top 20% of the CRP distribution had a three-fold increase in the relative
risk for CHD.
The relationship of serum CRP with the incidence of the first major CHD event
was examined in 936 men, 45 to 64 years of age, over an eight-year period in the
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MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) study
(Koenig et al., 1999). CRP values showed a strong positive relationship with the
incidence of CHD events. After adjustment for age, the hazard rate ratio for CHD was
1.60, and the relationship remained significant after adjusting for smoking behavior. It
was concluded that CRP was closely related to the risk of CHD in a large, randomly
selected cohort of initially healthy middle-aged men (Koenig et al., 1999).
Serum hsCRP (high sensitivity CRP) showed a significant inverse relationship
with the ankle-brachial pressure index (ABPI) at baseline and at 12-month follow-up in
subjects with peripheral artery disease (Vainas et al., 2005). ABPI is used as an indication
of severity of peripheral artery disease. Subjects were divided into three groups of equal
size according to baseline serum hsCRP levels. ABPI at baseline and at 12-months was
greatest in individuals with the lowest hsCRP levels and least in the subjects with the
highest hsCRP levels. Also, serum hsCRP was related to the combined end point "death
and/or any cardiovascular event" during a median 24-month follow-up period, suggesting
a relationship between hsCRP levels and hemodynamic function and future
cardiovascular events in patients with peripheral artery disease (Vainas et al., 2005).
In the Women’s Health Study, measurements of CRP and LDL-C were taken at
baseline in 27,939 apparently healthy women, who were followed for a mean of eight
years for the occurrence of myocardial infarction, ischemic stroke, coronary
revascularization, or death from cardiovascular causes (Ridker, Rifai, Rose, Buring, &
Cook, 2002). Although there was a minimal relationship between CRP and LDL, the
baseline levels of each had a strong linear relationship with the incidence of
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cardiovascular events. CRP and LDL-C measurements tended to identify different highrisk groups. Seventy-seven percent of all cardiovascular events occurred among women
with LDL-C levels below 4.14 mmol/liter (160 mg/dl), and 46 percent occurred among
those with LDL-C levels below 3.36 mmol/liter (130 mg/dl) (Ridker et al., 2002). It was
concluded that CRP level was a stronger predictor of cardiovascular events than the
LDL-C level (Ridker et al., 2002). Most importantly, the relative magnitude of hsCRP
predictive ability appears to outweigh that of other novel risk factors, including
homocysteine and lipoprotein (a) (Ridker et al., 2000; Ridker et al 2001).
Additional studies show a consistent positive association between CRP and future
cardiovascular events in both initially healthy subjects and patients with angina pectoris
(Danesh et al., 2000). The occurrence of fatal and non-fatal CHD and the relationship to
CRP was examined in 506 men who died from CHD or had a non-fatal myocardial
infarction and 1,025 men who remained free of such disease until 1996. Compared with
men in the bottom third of CRP levels at baseline, men in the top third had over a twofold greater risk of CHD after adjusting for age, town, smoking, vascular risk factors, and
indicators of socioeconomic status (Danesh et al., 2000).
The association of CRP with incident CHD among middle-aged adults in the
Atherosclerosis Risk In Communities (ARIC) study was examined in a prospective study
(Folsom, Aleksic, Catellier, Juneja, & Wu, 2002). CRP levels in two groups of subjects,
who developed CHD during 5 to 6 years of follow-up, were compared with two stratified
random samples of subjects without CHD. The relative risk of CHD was one and onehalf- to almost two-fold greater in the three highest quintiles of CRP compared with the
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two lowest CRP quintiles. This demonstrates that CRP was a moderately strong marker
of risk of CHD in this cohort of middle-aged adults, which is consistent with the role of
inflammation in the pathogenesis of CHD events (Folsom et al., 2002).
Results from the Honolulu Heart Program suggest that the relationship between
CRP levels and the risk of CVD may be stronger in men at low risk for CVD compared
with those whose risk is higher (Sakkinen et al., 2002; Curb et al., 2003). The estimated
risk of thromboembolic stroke increased significantly with rising CRP levels in middleaged men, in men without hypertension or diabetes, and in those who were never
cigarette smokers. For middle-aged men, there was a three-fold increase in the occurrence
of a thromboembolic stroke in men in the highest quartile of CRP levels compared with
men in the lowest quartile for CRP levels. In nonsmokers, there was a nearly six-fold
increase in thromboembolic stroke in men in the highest quartile of CRP levels compared
with men in the lowest quartile for CRP levels. The relationship between CRP and stroke
was independent of total cholesterol, BMI, alcohol intake, physical activity index, and
other risk factors. In contrast, the relationship between CRP levels and risk of
thromboembolic stroke were not as strong and were not significant in less healthy men or
those with other risk factors including past and current smokers, men greater than 55
years of age, and in men with hypertension or diabetes.
Similar to the association between CRP and stroke, the relationship between CRP
and myocardial infarction were stronger in middle-aged men, men without hypertension
or diabetes, and in those who were nonsmokers. Although small sample sizes could have
weakened the capacity to detect an association between CRP and myocardial infarction in
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higher-risk individuals, other studies have reported a stronger relationship between CRP
and CVD in nonsmoking women and in women without hypertension or diabetes
compared with women who smoked or were hypertensive or diabetic (Ridker et al.,
1998). In apparently healthy individuals who have an absence of many more
conventional risk factors, CVD can still occur (Rost, Wolf, Kase, Kelly-Hayes,
Silbershatz, Massaro, et al., 2001). In these individuals, the effects of inflammation may
have overriding importance in the development of CVD. The weaker association in older
or less healthy men and women could have several explanations. Although inflammation
may still be important, in the presence of other risk factors a high risk of CVD could
mask any residual, and perhaps weaker, effects of inflammation.
In a subgroup from the Caerphilly study, there was a positive association between
CRP and incident ischemic heart disease, mainly with fatal disease (Mendall, Patel,
Ballam, Strachan, & Northfield., 2000). CRP was significantly associated with several
risk factors including BMI, smoking and age. Interestingly, after adjustment for various
risk factors including BMI, smoking, low forced expiratory volume, height, low
childhood social class and age the association with all-incident ischemic heart disease and
ischemic heart disease death became non-significant, suggesting that although CRP levels
are raised in association with a variety of established cardiovascular risk factors, neither
CRP nor the systemic inflammation it represents appears to play a direct role in the
development of ischemic heart disease (Mendall et al., 2000).
A prospective, nested, case-control analysis involving 97 cases of sudden cardiac
death (SCD) among apparently healthy men enrolled in the Physician's Health Study was
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completed in order to compare the relative importance of CRP, homocysteine, and lipids
as long-term predictors of SCD (Albert, Ma, Rifai, Stampfer, & Ridker, 2002). Only
baseline CRP levels were significantly associated with the risk of SCD over the ensuing
17 years of follow-up. The increase in risk associated with CRP levels was primarily seen
among men in the highest quartile, who had a 2.78-fold greater risk of SCD compared
with men in the lowest quartile (Albert et al., 2002). In contrast to the positive
relationship observed for CRP, neither homocysteine nor lipid levels were significantly
associated with risk of SCD (Albert et al., 2002).
Based on the results of many prospective epidemiologic studies, CRP has
emerged as one of the most powerful predictors of CVD (Verma, Szmitko, & Ridker,
2005). CRP shows significant correlations with other established risk factors for CVD,
including age, systolic and diastolic blood pressure, smoking, BMI, physical inactivity,
total and HDL-C, triglycerides, and homocysteine (Rohde, Hennekens, & Ridker, 1999).
The predictive ability of hsCRP may even surpass that of LDL-C and/or the total
cholesterol-to-HDL-C ratio, currently the main CVD assessment tools (Ridker et al.,
1998; Rifai & Ridker, 2001). Screening for both LDL-C and CRP may provide better
prognostic information than screening for either alone. Finally, adding hsCRP to total
high-density lipoprotein cholesterol ratio significantly improves the predictive ability of
both tests.
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Physical Activity, Body Mass Index, C-Reactive Protein and Risk of Cardiovascular
Disease
As discussed previously, many studies have demonstrated that higher levels of
regular physical activity or cardiorespiratory fitness are associated with a reduced risk of
CVD. Also, increased adiposity, especially increased amounts of visceral fat, as
evidenced by increased values for BMI or WHR are related to greater risk for CVD. Both
lack of physical activity and increased adiposity appear to be linked to increased systemic
inflammation. In men and women classified with metabolic syndrome, based on NCEP
ATP III criteria, as well as individuals without metabolic syndrome, levels of CRP, serum
amyloid-A, TNF-α, IL-6 and fibrinogen were lower in individuals reporting LTPA
compared with those reporting no LTPA (Pitsavos, Panafiotakos, Chrysohoou, Kavouras,
& Stefanadis, 2005). Findings from Tamakoshi et al. (2002) suggest that being
overweight or obese increases CRP levels: therefore increasing the likelihood of CVD.
More specific discussions regarding the potential roles of CRP and homocysteine with
respect to CVD, and their association with physical activity and adiposity are presented in
the following sections.
Results of studies examining the effect of regular physical activity on CRP levels
are somewhat equivocal. Cross-sectional studies suggest that physical activity reduces
CRP levels (Colbert et al., 2004; Reuben, Judd-Hamilton, Harris, & Seeman, 2003), but
results from longitudinal studies are inconsistent. Cross-sectional data from the Health,
Aging and Body Composition Study showed lower CRP levels in elderly individuals, 70
to 79 years of age, reporting greater than 180 minutes of exercise per week compared
with those reporting no exercise (Colbert et al., 2004). Adjustment for body fatness
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attenuated the relationship between exercise and CRP slightly. Among individuals who
did not participate in regular exercise, individuals reporting greater physical activity had
lower CRP levels compared to those who reported less physical activity (Colbert, et al.,
2004). The relationships between recreational activity, house/yard work activity, work
activity, and total physical activity and CRP levels were examined in a cross-sectional
study of individuals, aged 70 to 79 years, who were in the top third of communitydwelling older persons with respect to physical and cognitive functioning (Reuben et al.,
2003). Both self-reported recreational activity or house and yard work activity were
independently associated with lower CRP levels. The association between high levels of
recreational activity and lower levels of CRP suggest a mechanism for the protective
effect of physical activity (Reuben et al., 2003).
The HERITAGE longitudinal study reported that CRP levels were reduced with
exercise training in individuals with high initial CRP levels (Lakka et al., 2005). High
sensitivity CRP was measured before and after a 20-week exercise training program in
652 sedentary healthy white and black men and women (Lakka et al., 2005). The study
sample was stratified according to baseline CRP levels using a recommended
classification system (low <1.0 mg/L; moderate 1.0-3.0 mg/L; high >3.0 mg/L). The
median decline in CRP was 1.34 mg/L in the high baseline CRP, but CRP levels did not
change in the groups with low or moderate CRP levels at baseline.
CRP levels were unchanged in middle-aged men with aerobic exercise training
over a six year period in the DNASCO study (Rauramaa et al., 2004), The progression of
atherosclerosis in middle-aged men was followed during a 6-year randomized, controlled
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trial in Eastern Finland. Men participated in low- to moderate-intensity aerobic exercise.
Atherosclerosis was quantified using the mean intima-media thickness of the carotid
artery using ultrasonography at baseline and at years two through six. High sensitivity
CRP levels were measured as a marker for inflammation. The progression of intimamedia thickness in the carotid artery did not differ between exercise and control groups,
and hsCRP levels were similar for the two groups. However, an analysis of a subgroup of
men who were not taking statin drugs showed that the 6-year progression of intima-media
thickness, adjusted for smoking and LDL-C level, systolic blood pressure, and waist
circumference, was 40% less in the exercise group (Rauramaa et al., 2004). Exercise
training did not have a significant effect on CRP in overweight or obese, BMI > 28
kg/m2, sedentary men and women, aged 60 years or older (Nicklas, Ambrosius, Messier,
Miller, Penninx, Loeser, et al., 2004). Subjects participated in combined weight training
and walking for one hour, three days per week.
Any relationship between physical activity or exercise and CRP levels may be due
at least in part to the effects of physical activity and exercise on adiposity and BMI. In the
beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study, individuals with greater
BMI values had higher levels of CRP, but there was not a significant relationship
between physical activity and CRP levels (Fredrikson, Hedblad, Nilsson, Alm, Berglund,
& Nilsson, 2004). Subjects with a BMI greater than 27.6 kg/m2 had 40% higher CRP
levels compared with individuals with lower BMI values. (Fredrikson et al., 2004)
A diet-induced weight-loss intervention, involving a weekly session with a
registered dietitian to provide education and support for lowering calorie intake, resulted
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in significantly greater reductions in CRP levels compared with no weight-loss treatment
(Nicklas et al, 2004). In a sample of obese, postmenopausal women, with mean age 56.4
years and a mean BMI of 35.6 kg/m2, plasma CRP levels were positively associated with
total body fatness and intra-abdominal body fat area (Tchernof et al., 2002). In a
subgroup of who participated in a weigh loss protocol, there was a mean reduction in
body weight of 14.5 kg, including a 10.4 kg reduction in fat mass. Visceral and
subcutaneous fat areas were reduced by -36.4% and -23.7%, respectively. Plasma CRP
levels declined 32%. Changes in body weight and in total body fat mass were both
positively associated with plasma CRP level reductions (Tchernof et al., 2002).
Body fatness or BMI apparently explains a large part of the relationship between
CRP and CVD risk. In a cross-sectional study of apparently healthy men and women,
mean ages of 49.7 and 50.6, respectively, the Pearson correlation between hsCRP and the
calculated 10-year Framingham Coronary Heart Disease Risk Score (FCRS) was lower
when adjusted for BMI (Rogowski, Shapira, Toker, Melamed, Shirom, Berliner, et al.,
2005). The reduction in the correlation was especially dramatic in women with a decline
from 0.25 to 0.09. The correlation between hsCRP and the 10-year FCRS is partly related
to the presence of obesity (Rogowski et al., 2005). Adiposity was strongly associated
with low-grade systemic inflammation in men and in women, with a particularly strong
relationship in women, especially for CRP (Thorand et al., 2006). In a cross-sectional
analysis of 641 men and 597 women, aged 55 to 74 years, participating in the populationbased KORA Survey 2000 in the area of Augsburg, Germany, measures of both total (fat
mass, BMI) and abdominal adiposity (waist circumference and WHR) were highly

45
correlated with markers of systemic inflammation including CRP (Thorand et al., 2006).
In women, percent body fat mass explained the highest percentage of the variability of
circulating acute-phase proteins, but in men, WHR explained the highest percentage of
the variability (Thorand et al., 2006).
In 405 healthy men and 454 healthy women from two large ongoing prospective
studies, physical activity was inversely associated with plasma levels of CRP. After
adjustment for BMI and leptin, as a surrogate for fat mass, most of these associations
were no longer significant. These results suggest that frequent physical activity is
associated with lower systemic inflammation, and that the relationship between physical
activity and CRP can be explained partially by a lower degree of obesity in physically
active subjects (Pischon, Hankinson, Hotamisligil, Rifai, 7 Rimm, 2003).

Homocysteine and Cardiovascular Disease
Homocysteine, a sulfur-containing metabolite of the amino acid methionine, is an
inflammatory marker for CVD and may contribute to the development of CVD. Elevated
plasma homocysteine concentrations are associated with a higher prevalence of CVD,
including occlusive disease of the coronary, cerebral, and peripheral vessels (Aronow &
Ahn, 2000; Kario, Duell, Matsuo, Sakata, Kato, Shimada, et al., 2001). Although crosssectional and case-control studies consistently show an association between
homocysteine and CVD, prospective studies have provided equivocal results (Cesari,
Rossi, Sticchi, & Pessina, 2005).
Although the precise role of plasma homocysteine in CVD is unclear,
homocysteine may induce the damage of the arterial wall and trigger the formation of
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atherosclerosis. Homocysteine may contribute to endothelial dysfunction and damage,
accelerated thrombin formation, inhibition of native thrombolysis, increased lipid
peroxidation through free radical formation, vascular smooth muscle cell proliferation
and monocyte chemotaxis (Splaver et al., 2004). Similar to CRP, homocysteine levels
change when damaging effects occur on the arterial wall (Perna, Ingrosso, Lombardi,
Acanfora, Satta, Cesare, et al., 2003), and increased homocysteine levels have been
shown to cause vessel fibrosis. Elevated homocysteine apparently induces tissue injury
by such mechanisms as oxidative stress, endothelial damage, and protein
homocysteinylation. There is an elevation of homocysteine during acute myocardial
infarction that may be related to an increase in the acute-phase reactant proteins
(Senarante, Griffiths, & Nagendran, et al., 2000). It has been hypothesized that the link
between homocysteine and CVD is mediated in part by activation of coagulation and
endothelial cell injury (Kario et al., 2001).
Most, but not all, observational epidemiological studies indicate that individuals
with higher homocysteine levels have increased risks of CVD and cerebrovascular events
(Nurk et al., 2002; Verhoef, Meleady, daly, Graham, Robinson, & Boers, 1999). The
magnitude ranges from approximately 20% in prospective studies to approximately 80%
in retrospective case-control studies (Splaver et al., 2004). However, the amount of
uncontrolled and uncontrollable confounding in all observational epidemiological studies
is as large as the postulated small to moderate effect size of homocysteine (Splaver et al.,
2004). Current evidence is necessary, but not sufficient to establish a cause-and-effect
relationship between homocysteine and CVD.
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Elevated plasma homocysteine concentration is considered a risk factor for CVD
and may also be associated with hypertension (Dinhavahi & Falkner, 2004). Some reports
describe a significant relationship between homocysteine and blood pressure levels, as
well as higher homocysteine levels in hypertensive individuals compared to normotensive
individuals. Other studies have reported that the effect of homocysteine disappears
following adjustment for other risk factors. Because homocysteine cosegregates with
other risk factors, it has been difficult to identify an independent effect of homocysteine
on CVD or hypertension (Dinavahi & Falkner, 2004).
In elderly Japanese subjects, high homocysteine levels were independently related
to CVD risk (Kario et al., 2001). After performing a 31-month follow-up on 500 men and
women, homocysteine levels were found to be an independent predictor of CVD
(Aronow and Ahn, 2000). In the Hordaland Homocysteine Study, participants with
preexisting CVD had higher mean homocysteine levels at entry into the study compared
to individuals without CVD (Nurk et al., 2002). Among subjects, aged 65 to 67 years at
baseline, the risk of CVD hospitalizations increased significantly with increasing
homocysteine levels. Following adjustment for multiple risk factors, elderly subjects with
the highest homocysteine levels (> 20.0 µmol/l) were twice as likely as subjects with the
lowest homocysteine levels (< 9.0 µmol/l) to be hospitalized for CVD. The relation
between homocysteine level and CVD hospitalizations was significantly stronger among
individuals with preexisting CVD than those without CVD. Although plasma
homocysteine levels were a strong predictor of CVD hospitalizations in elderly
individuals, especially those with preexisting CVD, there was not a statistically
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significant relationship between homocysteine levels and CVD in middle-aged
individuals (Nurk et al., 2002).
In a nested, case-control prospective study with extensive adjustment procedures,
homocysteine was an independent risk predictor for CVD-related mortality (Blacher,
Benetos, Kirzin, Malmejac, guize, & Safar, 2002). The adjusted hazard ratio for CVD
mortality was 1.22 for each one standard deviation (3.9 µmol/L) increment of
homocysteine (Blacher et al., 2002). A five-year study of physicians with elevated levels
of homocysteine found a three-fold greater risk of CVD (Lee, Sesso, Oguma, &
Paffenbarger, 2003).
Homocysteine was the strongest predictor of progression of CAD as assessed by
coronary calcium in older individuals over an eight to 80 month follow-up (Rasouli et al.,
2005). Individuals with elevated homocysteine (> 12 µmol/L) demonstrated a mean
increase in coronary calcium progression of 35% per year, while those with
homocysteine less than 12 µmol/L progressed at 17% per year. Homocysteine was more
closely related to CAD progression than CRP or cholesterol levels.

Physical Activity, Body Mass Index, Homocysteine and Risk of Cardiovascular Disease
Homocysteine levels have been shown to be associated to health-related
behaviors, including physical inactivity, diet and smoking (Chrysohoou, Panafiotakos,
Pitsavos, Zeimbekis, Zampelas, Papademetriou et al., 2004; Dinavahi & Falkner, 2004;
Nurk, Tell, Vollset, Nygard, Refsum, Nilsen, et al., 2004). In the Hordaland Study,
homocysteine levels were related to vitamin supplementation, smoking and changes in
body weight (Nurk et al., 2004). The Hordaland study examined the effect of lifestyle
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changes on homocysteine levels in 7,031 subjects who were either 41 to 42 years of age
or 65 to 67 years of age at baseline. Homocysteine levels were measured upon entry into
the study and six years later. Among the younger and older age groups, individuals who
started to supplement with vitamins during the follow-up period had significant
reductions in homocysteine concentrations (Nurk et al., 2004). In the younger subjects,
smoking cessation resulted in a decline in homocysteine concentrations. Changes in
body weight were inversely related to homocysteine. The changes noted in the Hordaland
Homocysteine study, which used a longitudinal design, were modest when compared
with the strong associations between homocysteine and lifestyle factors in cross-sectional
studies (Nurk et al., 2004).

Homocysteine and Cardiovascular Fitness
Although cardiovascular fitness and homocysteine levels showed a significant
inverse relationship in women, cardiovascular fitness and homocysteine levels were not
association in men. A total of 1,444 adults, aged 20 to 49 years, with data collected from
1999 to 2002 from the National Health and Nutrition Examination Survey (NHANES)
were used to examine the relationship between cardiovascular fitness and homocysteine
(Kuo, Yen, & Bean, 2005). After adjustment for age, race and BMI, there was a 0.70
ml/kg/min decrease in the estimated VO2max for each standard deviation increase in the
natural-log-transformed homocysteine level for women. After additional adjustment of
hypertension, diabetes, smoking status, alcohol intake, use of lipid-lowering agents,
physical activity, self-reported health condition, as well as levels of folate, vitamin B12,
creatinine, CRP, total cholesterol and hemoglobin there was a 1.18 ml/kg/min decline in
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the estimated VO2max for each standard deviation increase in the natural-log-transformed
homocysteine level in women (Kuo et al., 2005). There was no association between
cardiovascular fitness and homocysteine levels in men. However, another study found
fitness level, which was determined using maximal oxygen consumption, was inversely
related to homocysteine levels in men but not women (Coombe et al., 2004). In a crosssectional study of men and women, from the Athens, Greece area without a history of
CVD, aerobic exercise was related with significantly lower homocysteine levels as
compared to anaerobic or sedentary life although the magnitude of the difference (12%)
was small (Panagiotakos et al., 2005)
In general, studies in adults have demonstrated a significant relationship between
homocysteine and measures of body weight or adiposity. In young women, aged 25 to 30
years, and in older women, aged 60 to 65 years, homocysteine was positively associated
with BMI (Rasmussen et al., 2000). BMI was not related to homocysteine in a crosssectional study of healthy men and women, 40 to 67 years of age, with no history of
hypertension, diabetes mellitus, CHD or cerebrovascular disease, (El-Khairy, Ueland,
Nygard, Refsum, & Vollset, 1999). When comparing the relationship between
homocysteine and BMI, an increase in BMI was related to an increase in homocysteine
levels (Coombes, et al., 2004).

Conclusion
Many studies have found relationships between cardiovascular disease and
inflammatory markers, physical activity, and BMI. From the information gathered, the
relationship of these variables to cardiovascular disease is independent; each variable
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may affect the others. For example, an increase in physical activity will decrease BMI
and the occurrence of CVD. A six-year study performed by (Rauramaa et al. 2004)
indicates that there was not a significant change in the levels of CRP as a result of
exercise when comparing the control group to the testing group. One possible reason for
this is that the control group was allowed to engage in physical activity. Thus, the control
group’s CRP level would not be very different because they would have been doing to
the same routine as the testing group (Raramaa, et al., 2004). Overall, research has shown
that each of these factors are related to CVD in a positive or negative way, but since less
is known about the inflammatory markers, CRP and homocysteine, more research is
needed to determine their relationship to CVD.
The purpose of this study was to determine the relationship between BMI and
physical fitness, blood lipids, and inflammatory markers, as well as the relationship of
these variables to cardiovascular disease using the NHANES database.

CHAPTER III
MATERIALS AND METHODS

Data Source
The National Health and Nutrition Examination Survey (NHANES) is a program
of surveys and data collection designed to assess the health and nutritional status of adults
and children in the United States. The survey includes interviews and physical
examinations. NHANES is sponsored by the National Center for Health Statistics, which
is a part of the Centers for Disease Control and Prevention (CDC) of the U.S. Public
Health Service. NHANES data are available for public use.
The data used for the study were obtained by merging the 1999-2000 NHANES
and the 2001-2002 NHANES data sets. Information for the database was gathered by the
National Center for Health Statistics for the Centers for Disease Control and Health
Statistics. Physical examinations performed on the participants were administered at
Mobile Examination Centers (MEC) nationwide. Data collection involving medical and
dental examinations, as well as physiological measurements and laboratory tests were
conduction by a team of physicians and other highly trained medical personnel. The
NHANES detailed interview included demographic, socioeconomic, dietary, and
52
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health-related questions. Data from various surveys were used to determine the health
and nutritional status of the population.

Participants
There were a total of 10,291 participants, aged 20 to 85 years, available from the
1999 through 2002 NHANES databases. Only 8,485 (82%) of these participants were
included in the data analysis. Participants who were pregnant (n = 603), not examined at
a mobile examination center (n = 820), or had missing values for height (n = 164) and/or
weight (n = 125) were eliminated. The population used in this study was an adequate
sampling of 20 to 85 year old individuals classified as non-Hispanic white, non-Hispanic
black, Mexican-American, other Hispanic, and “others” that included multiracial in order
to yield significant results. An informed consent form was given to each participant
before they participated in the study.

Body Mass Index (BMI)
BMI was defined as body weight in kilograms divided by the square of height in
meters and categorized into four groups: underweight (< 18.5; n=144), normal weight
(18.5 - 24.9; n= 2,542), overweight (25.0 – 30.0; n = 3,014), and obese (> 30; n= 2,785)
(Center for Disease Control and Prevention, 2003).

Physical Fitness
For cardiovascular fitness level, individuals were categorized as low, moderate, or
high. Cardiovascular fitness was assessed using the heart rate response to a submaximal
graded exercise test in order to estimate the individual’s VO2 max.
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Dietary Folic Acid
Dietary folic acid intake was measured using a dietary interview questionnaire,
which was given by telephone or a computer. The dietary intake data was used to
estimate total intake of energy, nutrients, and non-nutrient food components from foods
and beverages consumed over a 24-hour period prior to the interview (midnight to
midnight). An NHANES computer-assisted dietary interview (CADI) system was the
form used for data collection and was developed using Power Builder™; several
databases (i.e., Quick List food list, brand name food list, and food amount unit list) that
are linked to the system. The CADI system provided a standardized interview format to
collect NHANES dietary interview data. The interviewers follow the prompts given by
the system screens in order to explain the dietary interview components to the
respondents.

C-Reactive Protein
For the NHANES database, serum CRP levels were measured using blood
samples that had been collected from each participant. At least 0.3 milliliters of serum
were collected. Participants were not required to fast before the blood sample was
obtained. Blood samples were taken at MEC laboratories, and frozen at a temperature of
-20○ Centigrade. Samples were sent to the University of Washington for analysis. A Dade
Behring Nephelometer II Analyzer System was used to measure CRP levels. (National
Health and Nutrition Examination Survey [NHANES], 2001).
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Homocysteine and Folate
Serum homocysteine and folate levels were measured using blood samples
obtained from the participants at the mobile examination centers (MEC). Participants
were required to fast before giving a blood sample to measure homocysteine levels. Once
the serum samples were collected, they were shipped to the Division of Environmental
Health Laboratory Sciences, National Center for Environmental Health, Centers for
Disease Control and Prevention for analysis. Samples were stored at a temperature of -70
degrees Celsius for approximately 8 months to three years before analysis. An Abbot
Homocysteine Assay was used to analyze the samples.

Serum total cholesterol, serum triglycerides, HDL-C, and Glucose
Serum total cholesterol, serum triglycerides, high-density lipoprotein levels, and
serum glucose levels were measured using blood samples collected at the MEC. . Fasting
blood samples were used for these analyses. Participants eligible for data collection must
have fasted for at least 8 hours and no less than 24 hours. Blood samples collected at
MEC laboratories were frozen at -20○ Centigrade and sent to the Johns Hopkins
University Lipoprotein Analytical Laboratory for analysis. Serum total cholesterol, HDLC, triglycerides, and glucose were determined using a Hitachi Model 917 Multichannel
Analyzer.
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Statistical Analysis
The 1999-2000 NHANES and 2001-2002 NHANES data sets were merged and
managed using SAS-callable SUDAAN statistical software (Research Triangle Institute,
Cary, NC). SUDAAN procedures are used to analyze data from complex sample surveys
and other observational and experimental studies. SUDAAN includes procedures for
obtaining descriptive statistics and regression modeling. SUDAAN is a statistical
program that accounts for the complex weighting of the survey data such as NHANES
99-02 sample.
For each variable, participant data were placed in the underweight, normal weight,
overweight, or obese group. Group means and standard errors of the mean were
calculated using SUDAAN software. Statistically significant differences between the
following groups were determined using Х2-analysis: underweight versus normal weight,
normal weight versus overweight, normal weight versus obese, and overweight versus
obese. A p value of < 0.05 was set as significant.

CHAPTER IV
RESULTS
Thirty percent of the subjects included in the data analysis were classified as
normal weight, which is based on a BMI value of greater than or equal to 20 kg/m2 and
less than 25 kg/m2. Only 1.7% of the subjects were classified as underweight, which is a
BMI value of less than 18.5 kg/m2. Thirty five and five-tenths percent of the subjects
were classified as overweight, which is a BMI greater than or equal to 25 kg/m2 but less
than 30 kg/m2, and 32.8% of the subjects were classified as obese, which is a BMI greater
than or equal to 30 kg/m2. Sixty-eight and three-tenths percent of the subjects were
classified as either overweight or obese.
The underweight group had a lower are at screening compared with the normal
weight group (Table 1). The overweight and obese groups were older at screening
compared to the normal weight group. There was no difference between the overweight
and obese group for age at screening.
The underweight group had lower waist circumference compared to the normal
weight group (Table 1). The overweight group had a greater waist circumference than the
normal weight group, and the obese group had a greater waist circumference compared to
the normal weight group. The obese group had a greater waist circumference compared
with the overweight group.
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The underweight group had lower serum triglyceride levels compared to the
normal weight group. Both the overweight and obese groups had greater serum
triglycerides compared to the normal weight group, and the obese group had greater
serum triglyceride levels compared to the overweight group (Table 2).
Table 1 Number of Subjects, Age at Screening, and Waist Circumference for
Underweight, Normal Weight, Overweight and Obese Groups.
Waist
Circumference
(cm)

Group

Number
of
Subjects

Percentage of
Subjects ( % )

Underweight

144

1.7

40.7 + 1.6 *

69.6 + 0.5 *

Normal
Weight

2542

30.0

43.8 + 0.4

82.0 + 0.2

Overweight

3014

35.5

47.5 + 0.4 **

95.7 + 0.2 **

Obese

2785

32.8

47.4 + 0.5 †

111.5 + 0.4 †‡

Age at Screening
(Years)

Note: Using body mass index (BMI), subjects were classified at underweight (< 18.5 kg/m2),
normal weight (> 18.5 kg/m2, < 25 kg/m2), overweight(> 25 kg/m2, < 30 kg/m2), and obese (> 30
kg/m2). Data for age at screening and waist circumference are presented as mean + standard
error of the mean
*
p < 0.001, underweight vs. normal weight
**
p < 0.001, overweight vs. normal weight
†
p < 0.001, obese vs. normal weight
‡
p < 0.001, obese vs. overweight

The underweight group had lower serum total cholesterol levels than the normal
weight group (Table 2). The overweight group and obese group had greater serum total
cholesterol levels than the normal weight group. There was no difference between the
overweight and obese groups for serum total cholesterol.
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The underweight group had greater serum high density lipoprotein cholesterol
(HDL-C) levels than the normal weight group (Table 2). Both the overweight and obese
groups had lower serum HDL-C levels than the normal weight group. The obese group
had lower HDL-C levels compared to the overweight group.
Table 2. Serum Triglycerides, Serum Total and High Density Lipoprotein Cholesterol,
and Serum Glucose for Underweight, Normal Weight, Overweight and Obese
Groups.
High Density
Lipoprotein
Cholesterol
(mmol/L)

Glucose
(mmol/L)

Triglycerides
(mmol/L)

Total
Cholesterol
(mmol/L)

Underweight

1.03 + 0.07 **

4.53 + 0.10 †

1.56 + 0.04 *

4.76 + 0.04 †

Normal Weight

1.24 + 0.03

4.96 + 0.03

1.48 + 0.01

5.00 + 0.04

Overweight

1.78 + 0.05 ††

5.27 + 0.03 ††

1.28 + 0.01 ††

5.30 + 0.03 ††

Obese

1.96 + 0.05 ‡#

5.24 + 0.03 ‡

1.19 + 0.01 ‡$

5.53 + 0.04 ‡$

Group

Note: Using body mass index (BMI), subjects were classified at underweight (< 18.5 kg/m2),
normal weight (> 18.5 kg/m2, < 25 kg/m2), overweight (> 25 kg/m2, < 30 kg/m2), and obese (>
30 kg/m2).
Data are mean + standard error of the mean.
*
**
†
††
‡
#
$

p < 0.05, underweight vs. normal weight
p < 0.01, underweight vs. normal weight
p < 0.001, underweight vs. normal weight
p< 0.001, overweight vs. normal weight
p < 0.001, obese vs. normal weight
p< 0.01, obese vs. overweight
< 0.001 obese vs. overweight
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The underweight group had lower serum glucose levels than the normal weight
group (Table 2). The overweight and obese groups had greater serum glucose levels
compared to the normal weight group. The obese group had greater serum glucose levels
compared to the overweight group.
Chi-square analysis showed significant differences for the percentage of
participants in each group who reported performing vigorous physical activity during the
prior 30 days. Thirty-three and eight-tenths percent of participants in the normal weight
group reported engaging in vigorous physical activity within the last 30 days. Only
24.3% of the participants in the underweight group reported performing physical activity
within the prior 30 days. In the overweight group, 31.8% of the participants reported
engaging in vigorous physical activity, which is similar to the normal weight group. Only
25.7% of the participants in the obese group reported doing vigorous physical activity
during the last 30 days.
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Table 3 Percentage of Participants Who Reported Participation in Vigorous Physical
Activity Over the Past 30 Days and Estimated Cardiorespiratory Fitness
(VO2max) for Underweight, Normal Weight, Overweight and Obese Groups.
Participants
Reporting Vigorous
Physical Activity,
Last 30 Days ( % )

Estimated
VO2max
(ml/kg/min)

24.3

41.0 + 1.8

33.8 *

41.5 + 0.4

Overweight

31.8

40.1 + 0.6

Obese

25.7

38.3 + 0.5 * **

Group
Underweight
Normal Weight

Note: Using body mass index (BMI), subjects were classified at
underweight (< 18.5 kg/m2), normal weight (> 18.5 kg/m2, < 25 kg/m2),
overweight (> 25 kg/m2, < 30 kg/m2), and obese (> 30 kg/m2). Estimated
VO2max was determined using a two-stage submaximal exercise test.
Data for participants reporting vigorous physical activity over the last 30
days are expressed as a percentage of the subjects for each BMI
classification.
* p < 0.001, obese vs. normal weight.
Data for estimated VO2max are mean + standard error of the mean.
* p < 0.001, obese vs. normal weight
** p< 0.001, obese vs. overweight.

There was no difference between the underweight and normal weight groups for
estimated VO2max (Table 3). Also, there was no difference between the overweight and
normal weight groups for VO2max. The obese group had a lower estimated VO2max
value compared to the normal weight and overweight groups.
The underweight group was not different from the normal weight group for serum
CRP level (Table 4). The overweight group and the obese group had greater CRP levels
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than the normal weight group, and the obese group had a greater CPR level than the
overweight group.
The underweight and normal weight groups were not different for serum
homocysteine levels (Table 4). The overweight group had greater homocysteine levels
compared to the normal weight group. The homocysteine level for the obese group was
not different compared with the homocysteine levels for the normal weight and
overweight groups.
There was no difference for the underweight and normal weight groups with
respect to the age at which they were told that they had CHD (Table 4). Both the
overweight and obese groups were at a younger age when informed that they had CHD
compared to the normal weight group. There was no difference between the obese and
overweight groups with respect to the age at which they were told that they had CHD.
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Table 4 Inflammatory Markers, and Age When the Individual Was Informed that They
Had Coronary Heart Disease (CHD) for Underweight, Normal Weight,
Overweight and Obese Groups.

Group

C-Reactive
Protein
(mg/dL)

Homocysteine
(umol/L)

Age when told
had CHD
(years)

Underweight

0.20 + 0.04

8.03 + 0.18

57.5 + 9.0

Normal Weight

0.27 + 0.01

8.26 + 0.08

59.7 + 1.9

Overweight

0.38 + 0.02 †

8.57 + 0.08 **

55.5 + 1.4 *

Obese

0.62 + 0.02 ‡ #

8.47 + 0.11

52.6 + 1.6 ††

Note: Using body mass index (BMI), subjects were classified at underweight (< 18.5 kg/m2),
normal weight (> 18.5 kg/m2, < 25 kg/m2), overweight (> 25 kg/m2, < 30 kg/m2), and obese
(> 30 kg/m2).
Data are mean + standard error of the mean.
* p < 0.05, overweight vs. normal weight
**p < 0.01, overweight vs. normal weight
† p < 0.001, overweight vs. normal weight
††p< 0.01, obese vs. normal weight
‡ p < 0.001, obese vs. normal weight
# p< 0.001, obese vs. overweight

Dietary folic acid intake was not different between the underweight and normal
weight groups. The overweight and normal weight groups did not differ for dietary folic
acid intake. The obese group has a significantly lower dietary folic acid consumption
compared to the normal weight group, but was not different compared with the
overweight group.
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Serum folate levels were not different between the underweight and normal
weight groups or between the overweight and normal weight groups. Serum folate was
lower in the obese group compared to the normal weight and overweight groups.
Table 5. Homocysteine, Dietary Folic Acid and Serum Folate for Participants Classified
as for Underweight, Normal Weight, Overweight and Obese Groups.

Group

Dietary Folic
Acid
(µg)

Homocysteine
(µmol/L)

Serum Folate
(nmol/L)

Underweight

8.03 + 0.18

236.8 + 52.6

34.0 + 2.3

Normal
Weight

8.26 + 0.08

207.1 + 8.7

35.4 + 0.7

Overweight

8.57 + 0.08 *

194.8 + 6.4

34.6 + 0.5

Obese

8.47 + 0.11

181.0 + 5.1 **

31.4 + 0.6 **‡

Note: Using body mass index (BMI), subjects were classified at underweight (< 18.5
kg/m2), normal weight (> 18.5 kg/m2, < 25 kg/m2), overweight (> 25 kg/m2, < 30
kg/m2), and obese (> 30 kg/m2).
Data are mean + standard error of the mean.
*
**
‡

p < 0.01, overweight vs. normal weight
p < 0.001, obese vs. normal weight
p < 0.001, obese vs. overweight

CHAPTER V
DISCUSSION
Using the data using the combined data sets from 1999-2000 and 2001-2002
NHANES, 32.8% of the participants were classified as overweight and 68.3% of the
participants in were classified as either overweight or obese. Most reports on the
prevalence of overweight and obesity have used NHANES so similar values for
prevalence would be expected. Using data from the 2003 – 2004 NHANES data set, the
calculated prevalence of obesity for adults, 20 years of age and older, was 32.2% (Ogden,
Carroll, Curtin, McDowell, Tanak, & Flegal, 2006). This included an obesity prevalence
of 31.1% for men and 33.2% for women. Data from 1999-2000 NHANES showed a
prevalence of obesity of 30.5% and a prevalence of overweight of 64.5% (Flegal.,Carroll,
Ogden, & Johnson, 2002).
Multiple factors have contributed to the dramatic rise in the prevalence of
overweight and obesity in the United States. These factors include social, economic and
cultural changes over the prior century. Since body weight is determined by energy
balance, the balance between calories consumed and calories expended determines
whether body weight is decreased, maintained, or increased. Physical activity is a major
determinant of energy expenditure; therefore, declining participation in physical activity
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is recognized as a key contributing factor to the high prevalence of overweight and
obesity.
In general, the major finding of the present study was that overweight and obesity
were associated with a poor serum lipid profile, higher serum glucose levels, lower
participation in physical activity and a lower physical fitness level, elevated serum levels
of inflammatory markers for CVD, and a younger age at which participants were
informed that they had CAD. Using survey data, it is not possible to determine the exact
cause of the younger age at which overweight and obese participants were told that they
had CAD, but physical activity levels and increased body fatness are both likely to be
contributing factors as discussed below. Additionally, some of the effects of physical
activity in improving serum lipid and glucose levels and even possible markers for
inflammation may be mediated in part by the effect of physical activity in maintaining a
lower body weight.
The poor serum lipid profile of the overweight and obese individuals included
elevated serum triglycerides and total cholesterol and lower HDL-C compared with the
normal weight group. This is consistent with the reported association of higher total
cholesterol levels and reduced HDL-C in overweight and obese individuals, which are
partially reversed by weight loss (Pasanisi, Contaldo, De Simone, & Mancini, 2001;
Poirier & Despres, 2001). The blood lipid profiles of the overweight and obese groups
was related to participants being told at a younger age that they had CAD, and it also is
consistent with an increased risk for CVD (Anderson et al., 1987; Benfante & Reed,
1990; Huxley et al., 2002; Martin et al., 1986). The obese group in the present study had
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a lower participation rate in physical activity also. Physical activity improves blood lipid
profiles (Poirier & Despres, 2001). The obese group may have elevated serum total
cholesterol and reduced HDL-C due to increased body weight and lower physical activity
levels. Finally, there is a close relationship between physical activity, overweight and
obesity, cholesterol levels and risk for CHD (Garrison et al., 1980).
The elevated blood glucose levels in the overweight and obese individuals are
consistent with the decline in insulin insensitivity and reduced glucose uptake that
accompany increased body fatness (Reaven, 2005). Higher blood glucose levels are an
indicator of impaired glucose tolerance or increased resistance to insulin. Elevated blood
glucose had been linked to an increased risk of CVD (Bowman & Armitage, 2002:
Petersen & McGuire, 2005; Schnell, 2005). For example, CVD is a major cause of the
reduction in life expectancy in patients with diabetes (Schnell, 2005). Seventy-five
percent of diabetic patients die prematurely of cardiovascular complications. Both prediabetes and diabetes highly pre-dispose to cardiovascular alterations, and even serum
glucose levels at the upper end of the normal range may predispose individuals to an
increased risk of CVD (Schnell, 2005). Furthermore, elevated serum glucose levels have
been linked with low grade inflammation (Barzilay & Freedland, 2003).
In the present study, one-third of the normal weight participants reported
engaging in vigorous physical activity within the last 30 days. The rate of participation in
vigorous physical activity was 31.8% in the overweight individuals, which is similar to
that for the normal weight individuals. However, only one-fourth of the obese
participants reported performing vigorous physical activity. Since physical activity is an
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important component of a healthy lifestyle that includes weight maintenance or weight
loss it is not surprising that a lower proportion of participants in the obese group reported
participation in vigorous physical activity. The lack of difference between the normal
weight and overweight groups was unexpected; however, the nature of this general
question may not differentiate well between the actual amount and intensity of physical
activity in which the participants in the various groups engaged.
Also in the present study, only the obese group had a lower physical fitness level
compared with the normal weight group based on estimated VO2max. This is consistent
with the lower percentage of obese individuals reporting engaging in vigorous physical
activity. It is worth noting that the overweight group had similar VO2max values
compared with the normal weight group. One might expect that as a group,
cardiorespiratory fitness would be decreased to at least a small degree in the overweight
participants. This lack of difference may be due to the test used. In NHANES, VO2max
was assessed using a submaximal two-stage exercise test rather than an incremental
exercise test to maximum oxygen uptake. An exercise test to obtain an accurate
maximum oxygen consumption is time consuming and would not be feasible when
collecting data on large numbers of people. Also, there is an increased risk of adverse
cardiovascular events during maximal exercise tests in men over 40 years of age and
women greater than 50 years of age. However, the two-stage, submaximal test used in
NHANES could have resulted in an increased measurement error. Also, there was little
numerical difference for the estimated VO2max between the groups. The numerical
difference between the normal weight and obese groups was 3.2 ml/kg/min. Although
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this was a statistically significant difference, the absolute difference was rather small.
Also, the estimated VO2max values for the groups appear to be slightly higher than
published norms (American College of Sports Medicine, 2000).
From the present results, it can be concluded that there is a slight relationship
between BMI and cardiorespiratory fitness. The extent to which elevated BMI or reduced
cardiorespiratory fitness and lower physical activity participation contributed to the lower
age at which participants in the obese group were informed that they had CAD cannot be
determined from the present data. Many studies have reported a link between moderate
and high levels of physical activity or increased physical fitness and a decreased risk of
CVD and mortality due to CVD. Studies have demonstrated that higher levels of regular
physical activity (Anderson, et al, 1997, Leon et al., 1987) and cardiorespiratory fitness
(Lakka, et al., 1994) are associated with a reduced risk of CVD. Good cardiorespiratory
fitness was shown to be associated with slower progression of early atherosclerosis in
middle-aged men (Lakka et al., 2001). The relative risk of myocardial infarction for study
participants in the upper third for maximal oxygen uptake (> 2.7 liters per minute) was
0.26 after adjustment for age and other variables as compared with the participants in the
lowest third of VO2max (Lakka et al., 1994). Higher levels of both leisure-time physical
activity and cardiorespiratory fitness show strong, graded, inverse relationships with the
risk of acute myocardial infarction (Lakka et al., 1994). The present results for
participation in physical activity, cardiorespiratory fitness and being informed of having
CAD are consistent with the published literature showing that increasing physical activity
and improved physical fitness is related to a reduced incidence of CVD.
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The results of the present study are consistent with studies that have reported that
inflammatory markers, such as CRP and homocysteine, are elevated in overweight and
obese individuals (Tamakoshi et al., 2002; Thorand et al., 2006). Findings from King et
al. (2003) and Tamakoshi et al. (2002) suggest that being overweight or obese increases
CRP levels, thus increasing the likelihood of CVD. Of the two inflammatory markers
examined in the present study, the differences between groups were the most dramatic for
serum CRP levels. Serum CRP levels were lowest in subjects categorized as underweight
or normal weight. Serum CRP levels were 41% greater in the overweight subjects
compared to subjects of normal weight. In obese individuals, CRP levels were 130%
greater than in normal weight subjects and 63% greater in obese subjects compared with
overweight subjects. Homocysteine levels also were greater in overweight and obese
individuals compared to subjects who were underweight or normal weight; however the
between group differences were not as dramatic as the between group differences for
CRP. Using 2,258 non-Hispanic Whites, 1,856 non-Hispanic Blacks, and 1,584 MexicanAmerican participants drawn from the NHANES database, there was a negative
association between serum homocysteine and BMI in non-Hispanic blacks and MexicanAmericans but not in non-Hispanic whites (Ganji & Kafai, 2004). In the present study,
participants were not divided into groups based on race or ethnicity. The more dramatic
relationship between CRP and body weight category compared with homocysteine and
body weight category suggests that body weight may have a more dramatic effect on
CRP levels than homocysteine. A population-based, cross-sectional study using data from
NHANES from 1999 to 2002 examined a total of 1,444 adults between the ages of 20 to
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49 years (Kuo et al., 2005). There was significant, inverse relationship between estimated
VO2max and homocysteine levels in women, but there was no relationship in men (Kuo
et al., 2005). These data suggest that physical activity may effect homocysteine levels, at
least in females. In summary, these results are consistent with recent reports of a link
between increased body fatness and low-grade inflammation. Also, increased adiposity,
especially increased amounts of visceral fat, as evidenced by increased values for BMI
are related to greater risk for CVD. Both lack of physical activity and increased adiposity
appear to be linked to increased systemic inflammation.
As would be expected subjects who were either overweight or obese were
informed at a younger age that they had CAD compared to subjects who were
underweight or normal weight. Subjects in the overweight group were 4.2 years younger
than subjects in the normal weight group when informed that they had CHD, and subjects
in the obese group were 7.1 years younger. These data are consistent with studies
reporting an increased risk of CVD or CHD in individuals who are overweight and obese
(Haapanen et al., 1997; Rodriguez et al., 1994).
Dietary folic acid intake and serum folate levels have strong, inverse relationships
with serum homocysteine levels (Ganji and Kafai, 2004). For example, homocysteine
concentrations in young women, aged 25 to 30 years, and in 288 older women, aged 60 to
65 years, were inversely related to total folate consumption and folic acid intake from
supplements (Rasmussen et al., 2000). Using data from the third NHANES, 1988-1994,
serum folate was reported to be a strong determinant of homocysteine levels (Ganji and
Kafai, 2004). In the present study, dietary folic acid and serum folate levels cannot
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explain the higher homocysteine levels in the overweight group compared to the normal
weight group. The overweight group had significantly higher homocysteine levels, even
though there dietary folic acid consumption and serum folate were not different compared
to the normal weight group. Dietary folic acid intake and serum folate levels were
significantly lower only in the obese group compared to the normal weight group, but the
homocysteine levels were not significantly different compared to the normal weight
group. Dietary folic acid intake and serum folate levels cannot explain the results for
homocysteine levels in this study, suggesting that BMI or physical activity do effect
homocysteine levels..

Summary and Conclusion
The purpose of this study was to determine the relationship between BMI and
physical fitness, blood lipids, and inflammatory markers, as well as the relationship of
these variables to CVD using the National Health and Nutrition Examination Survey
(NHANES) 1999 - 2002 database. Our results support the research hypotheses: 1)
individuals who were normal weight based on BMI classification had higher levels of
physical fitness compared to obese individuals; 2) individuals who were normal weight
had lower serum triglyceride and total cholesterol levels compared with overweight and
obese individuals; 3) individuals who were normal weight had lower serum glucose
levels compared with overweight and obese individuals; 4) individuals who were normal
weight had lower serum levels of CRP compared to the overweight and obese
individuals, as well as lower levels of homocysteine compared with the overweight
group; and, 5) individuals who were in the normal weight group had a greater age when
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they were told that they had CHD compared with overweight and obese individuals. In
summary, the results of the present study show that overweight and obesity were
associated with a poor serum lipid profile, higher serum glucose levels, lower
participation in physical activity and a lower physical fitness level, elevated serum levels
of inflammatory markers for CVD, and a younger age at which participants were
informed that they had CAD.
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